<SEC-DOCUMENT>0001437749-14-017906.txt : 20141003
<SEC-HEADER>0001437749-14-017906.hdr.sgml : 20141003
<ACCEPTANCE-DATETIME>20141003083738
ACCESSION NUMBER:		0001437749-14-017906
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20141002
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141003
DATE AS OF CHANGE:		20141003

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		141138357

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>govx20141002_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD><TITLE>govx20141002_8k.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<HR style="MARGIN-BOTTOM: 2px; BORDER-TOP: medium none; HEIGHT: 3px; BORDER-RIGHT: medium none; WIDTH: 100%; BORDER-BOTTOM: medium none; COLOR: #000000; BORDER-LEFT: medium none; MARGIN-TOP: 0px; BACKGROUND-COLOR: #000000">

<HR style="BORDER-TOP: medium none; HEIGHT: 1px; BORDER-RIGHT: medium none; WIDTH: 100%; BORDER-BOTTOM: medium none; POSITION: relative; COLOR: #000000; BORDER-LEFT: medium none; MARGIN-TOP: 0px; TOP: 0px; BACKGROUND-COLOR: #000000">

<P id=PARA3 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>WASHINGTON, D.C. 20549</B></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><STRONG></STRONG>&nbsp;</P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">__________________</FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA9 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FORM 8-K </B></FONT></P>
<P id=PARA10 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA11 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CURRENT REPORT </B></FONT></P>
<P id=PARA12 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Pursuant to Section 13 or 15(d) of the </B></FONT></P>
<P id=PARA13 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Securities Exchange Act of 1934 </B></FONT></P>
<P id=PARA14 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA15 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Date of report (Date of earl</B><B>iest event reported): October 2, 2014</B></FONT></P>
<P id=PARA16 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">__________________</P>
<P id=PARA17 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P id=PARA19 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><B>GEOVAX LABS, INC.</B></FONT></P>
<P id=PARA20 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(Exact name of registrant as specified in Charter) </B></FONT></P>
<P id=PARA21 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA22 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<TABLE id=TBL35  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 31.3%; VERTICAL-ALIGN: top">
<P id=PARA24 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Delaware</B></FONT></P></TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<P id=PARA25 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 31.3%; VERTICAL-ALIGN: top">
<P id=PARA26 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>000-52091</B></FONT></P></TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<P id=PARA27 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 31.3%; VERTICAL-ALIGN: top">
<P id=PARA28 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>87-0455038</B></FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 31.3%; VERTICAL-ALIGN: top">
<P id=PARA29 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(State or other jurisdiction of</B></FONT></P>
<P id=PARA30 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>incorporation or organization)</B></FONT></P></TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<P id=PARA31 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 31.3%; VERTICAL-ALIGN: top">
<P id=PARA32 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(Commission File No.)</B></FONT></P></TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<P id=PARA33 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></TD>
<TD style="WIDTH: 31.3%; VERTICAL-ALIGN: top">
<P id=PARA34 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(IRS Employee Identification No.)</B></FONT></P></TD></TR></TABLE>
<P id=PARA36 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA37 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>1900 Lake Park Drive</B></FONT></P>
<P id=PARA38 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Suite 380</B></FONT></P>
<P id=PARA39 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Smyrna, Georgia 30080</B></FONT></P>
<P id=PARA40 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(Address of Principal Executive Offices) </B></FONT></P>
<P id=PARA41 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA42 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(678) 384-7220</B></FONT></P>
<P id=PARA43 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(Issuer Telephone number) </B></FONT></P>
<P id=PARA44 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA45 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA46 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).</FONT></P>
<P id=PARA47 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA48 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">[&nbsp;&nbsp; ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P id=PARA49 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA50 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">[&nbsp; &nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</FONT></P>
<P id=PARA51 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA52 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">[&nbsp; &nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</FONT></P>
<P id=PARA53 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA54 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">[&nbsp; &nbsp;] Pre-commencement communications pursuant to Rule 13e-4&#169; under the Exchange Act (17 CFR 240.13(e)-4(c))</FONT></P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA55 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</P>
<HR style="MARGIN-BOTTOM: 2px; BORDER-TOP: medium none; HEIGHT: 1px; BORDER-RIGHT: medium none; WIDTH: 100%; BORDER-BOTTOM: medium none; COLOR: #000000; BORDER-LEFT: medium none; MARGIN-TOP: 0px; BACKGROUND-COLOR: #000000">

<HR style="MARGIN-BOTTOM: 0px; BORDER-TOP: medium none; HEIGHT: 3px; BORDER-RIGHT: medium none; WIDTH: 100%; BORDER-BOTTOM: medium none; POSITION: relative; COLOR: #000000; BORDER-LEFT: medium none; MARGIN-TOP: 0px; TOP: 0px; BACKGROUND-COLOR: #000000">

<DIV id=PGBK56  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR56  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM56  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR56  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA56.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA57 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">This Form 8-K and other reports filed by GeoVax Labs, Inc. (the &#8220;registrant&#8221;) from time to time with the Securities and Exchange Commission (collectively the &#8220;Filings&#8221;) contain forward looking statements and information that are based upon beliefs of, and information currently available to, the registrant&#39;s management as well as estimates and assumptions made by the registrant&#39;s management. When used in the Filings the words &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;future&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221; or the negative if these terms and similar expressions as they relate to the registrant or the registrant&#39;s management identify forward looking statements. Such statements reflect the current view of the registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the registrant&#39;s industry, operations and results of operations and any businesses that may be acquired by the registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.</FONT></P>
<P id=PARA58 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA59 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Events</B></FONT></P>
<P id=PARA60 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA61 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25; TEXT-INDENT: 54pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On October 2, 2014 we issued a press release announcing the initiation of an Ebola vaccine development program. A copy of the press release is attached to this Current Report.</FONT></P>
<P id=PARA62 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA63 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statements and Exhibits</B></FONT></P>
<P id=PARA64 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA65 style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 54pt; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exhibit 99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release</FONT></P>
<P id=PARA66 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 63pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -63pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA67 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SIGNATURES</B></FONT></P>
<P id=PARA68 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA69 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25; TEXT-INDENT: 54pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P id=PARA70 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA71 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dated: October 3, 2014</FONT></P>
<P id=PARA72 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL82  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD vAlign=top width="50%">
<P id=PARA82.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="38%" colSpan=2>
<P id=PARA82.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">GEOVAX LABS, INC.</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA82.3 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA82.4 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA82.5 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA82.6 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA82.7 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA82.8 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA82.9 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width="35%" noWrap align=left>
<P id=PARA82.10 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA82.11 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="BORDER-BOTTOM: #ffffff solid; TEXT-ALIGN: left" vAlign=top width="50%" align=left>
<P id=PARA82.12 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD style="BORDER-BOTTOM: #ffffff solid; TEXT-ALIGN: left" vAlign=top width="3%">
<P id=PARA82.13 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By: </FONT></P></TD>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=top width="35%" noWrap align=left>
<P id=PARA82.14 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/&nbsp;</FONT>Mark W. Reynolds</P></TD>
<TD style="BORDER-BOTTOM: #ffffff solid" vAlign=top width="12%">
<P id=PARA82.15 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA82.16 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA82.17 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA82.18 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mark W. Reynolds</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA82.19 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA82.20 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA82.21 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA82.22 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief Financial Officer</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA82.23 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR></TABLE>
<P id=PARA73 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp; <FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD><TITLE>ex99-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA59 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT>&nbsp;</P>
<P style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exhibit 99.1</B></FONT></P>
<P id=PARA60 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: left; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P><IMG src="govx.jpg" width=270 height=94>
<P id=PARA1 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA2 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>GeoVax Announces </B><B>Initiation of</B></FONT></P>
<P id=PARA5 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Ebola Vaccine Development Program</B></FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>GeoVax</I><I> Developing Vaccines for Epidemic Response as Well as for Routine Immunization</I></FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA9 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>ATLANTA, GA, October 2, 2014 &#8211;</B> GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel DNA/MVA platform technology, today announced that it has initiated a new program for the development of a safe and effective vaccine to prevent Ebola infection.</FONT></P>
<P id=PARA12 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA11 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">With a fast-moving epidemic threatening large populations in Africa, and no proven therapy available, an effective vaccine against Ebola is desperately needed. The GeoVax recombinant MVA platform is uniquely suited to deliver a potent and safe vaccine capable of protecting people against Ebola hemorrhagic fever. GeoVax&#8217;s Ebola vaccine development efforts will be facilitated by the Company&#8217;s close proximity to, and collaboration with, the U.S. Centers for Disease Control (CDC) in Atlanta and its experts and Biosafety Level 4 (BSL-4) facilities for testing vaccine responses against lethal hemorrhagic viruses.</FONT></P>
<P id=PARA14 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Since 1976, when Ebola was first discovered, over 20 outbreaks have occurred. Ebola naturally infects animals including bats, creating a reservoir of Ebola that, like rabies, cannot be eradicated completely. An effective vaccine against Ebola would dramatically reduce the epidemic spread of infections as well as the transmission of Ebola from its natural animal hosts to humans.</FONT></P>
<P id=PARA16 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA15 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">GeoVax is developing two Ebola vaccines, GOVX-E301 and GOVX-E302. Both are recombinant MVA (modified vaccinia Ankara) vaccines designed to produce non-infectious virus-like particles (VLPs) displaying the Ebola virus glycoprotein. GOVX-E301 is being developed as a single-dose vaccine for epidemic response against the ZEBOV strain of Ebola, the virus responsible for the current outbreak. GOVX-E302 is being developed for routine immunization and is designed to protect against all three versions of Ebola known to be lethal in humans. GOVX-E302 is anticipated to be used in a two-dose regimen. </FONT></P>
<P id=PARA18 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA17 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">GeoVax&#8217;s recombinant MVA vaccines have been successfully evaluated in clinical trials against HIV, in which they have shown excellent safety and immunogenicity. Advantages of the GeoVax rMVA platform include:</FONT></P>
<P id=PARA20 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB21  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA22 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U></U></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA23 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Safety:</U> GeoVax&#8217;s rMVA vaccines have demonstrated outstanding safety in human clinical trials.</FONT></P></TD></TR></TABLE>
<P id=PARA25 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB26  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA27 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U></U></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA28 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Immunogenicity:</U> GeoVax&#8217;s rMVA technology produces virus-like particles that raise robust immune responses.</FONT></P></TD></TR></TABLE>
<P id=PARA30 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB31  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA32 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U></U></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA33 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Durability:</U> GeoVax&#8217;s rMVA technology raises highly durable vaccine responses, by far the most durable in the field of HIV vaccines.</FONT></P></TD></TR></TABLE>
<P id=PARA35 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB36  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA37 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U></U></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA38 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><U>Limited Pre-existing Immunity to MVA:</U> GeoVax&#8217;s rMVA vector is based on an attenuated smallpox virus. Following smallpox eradication in 1980, smallpox vaccinations were stopped, leaving all but the elderly unvaccinated and without pre-existing immunity. </FONT></P></TD></TR></TABLE>
<P id=PARA40 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA39 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Robert McNally, PhD, GeoVax&#8217;s President and CEO, commented, &#8220;We feel an urgency in launching this new program to develop a safe and effective Ebola vaccine. For the current epidemic, containment efforts have proven difficult to institute, accentuating the world&#8217;s lack of preparation for a runaway Ebola epidemic and the need for a vaccine. With the knowledge gained from our experience in developing HIV vaccines, we believe our MVA-vectored Ebola vaccines have the unique attributes required for success and will offer superior results over other Ebola vaccines in development. We are therefore fast tracking this program with the objective of having an &#8216;epidemic-ready&#8217; GOVX-E301 vaccine available by 2016.&#8221;</FONT></P>
<P id=PARA42 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA41 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#8220;Our Ebola vaccine program is a natural extension of our MVA vaccine delivery platform,&#8221; Dr. McNally continued. &#8220;It is a complementary asset to our lead HIV vaccine program, to which we remain committed. We continue to be actively engaged in discussions with the HIV Vaccine Trials Network (HVTN) and the National Institutes of Allergy and Infectious Disease (NIAID) regarding the design of our next clinical study and various trial designs are being considered.&#8221;</FONT></P>
<P id=PARA44 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT></P>
<DIV id=PGBK61  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR61  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM61  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR61  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA61.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA43 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>About GeoVax</B></FONT></P>
<P id=PARA46 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA45 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">GeoVax Labs, Inc. (OTCQB: GOVX) is a biotechnology company developing human vaccines using its novel DNA/MVA vaccine delivery platform. The Company&#8217;s lead development program is focused on vaccines to prevent, and treat, Human Immunodeficiency Virus (HIV) infections. GeoVax&#8217;s unique, two component HIV vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV antibody and anti-HIV T cell immune responses. GeoVax&#8217;s DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Priming and boosting can also be done with the MVA. Both the DNA and MVA express the three major proteins of the HIV virus: Gag, Pol, and Env, and produce non-infectious virus-like particles. GeoVax&#8217;s vaccines are unique in expressing virus-like particles that display the native form of the trimeric membrane-bound HIV-1 envelope glycoprotein. Clinical trials for GeoVax&#8217;s preventive HIV vaccines have been conducted by the US National Institutes of Health-supported HIV Vaccine Trials Network (HVTN) with funding from the National Institute of Allergy and Infectious Disease (NIAID). Overall, GeoVax&#8217;s vaccines, in various doses and combinations, have been tested in close to 500 humans. www.geovax.com</FONT></P>
<P id=PARA48 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA47 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I><B>Forward-Looking Statements</B></I></FONT></P>
<P id=PARA50 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA49 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act</I><I>.</I><I> These statements are based on management&#39;s current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax&#39;s vaccines will be safe for human use, GeoVax&#39;s vaccines will effectively prevent HIV</I><I> or Ebola infection </I><I>in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax&#39;s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax&#39;s filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax&#39;s Form 10-K</I><I>.</I></FONT></P>
<P id=PARA51 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA52 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>INVESTOR CONTACT</B></FONT></P>
<P id=PARA53 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA54 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Adam S. Holdsworth</FONT></P>
<P id=PARA55 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ProActive Capital Group&nbsp;</FONT></P>
<P id=PARA56 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">646.862.4607</FONT></P>
<P id=PARA57 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">www.ProActiveCapital.com</FONT></P>
<P id=PARA58 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>&nbsp;</I></FONT></P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><EM></EM>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><EM></EM>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><EM></EM>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><EM></EM>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><EM></EM>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><EM></EM>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">###</P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>govx.jpg
<TEXT>
begin 644 govx.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X1"X17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````>````<@$R``(````4````D(=I``0````!````I````,0!+`````$`
M``$L`````0``061O8F4@4&AO=&]S:&]P($-3,R!-86-I;G1O<V@`,C`Q,SHP
M-3HP,B`R,3HR.#HT-0```J`"``0````!```%W*`#``0````!```""@``````
M```&`0,``P````$`!@```1H`!0````$```$2`1L`!0````$```$:`2@``P``
M``$``@```@$`!`````$```$B`@(`!`````$```^-`````````$@````!````
M2`````'_V/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<
M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_``!$(`#<`H`,!(0`"$0$#$0'_Q``?```!!0$!`0$!`0``
M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#
M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z*`"FO(D2%Y'5%'4L<"@#"O?&
M_A?3V*W&NV(<<%(Y1(P^H7)%8-]\8/"5H/W,]U>'N(+<C'_?>VMHT*DNAG*K
M%=3+D^-^CD$6VDZC*_96V+_(FHH_BUK=Y_QX>!KV<=F221_T6+^M:_5;?%*Q
M'M[_``HG3QWXZGYB\"S+_P!=`X_F!4O_``EWQ$/W?!<?XN?_`(JE[*DOM!SU
M/Y1?^$K^(O?P7%^$O_V5*/&/CY/O^!]W^[-_^NE[.E_,/GJ?RB?\+#\5PG%Q
M\/-1([F)W;]!&?YU2\2?$V63P?J2C2+_`$J^<+;QFZ0K]_.XKT.0H;G'!*^M
M-4(W5I7$ZKMJK$7@;Q/X3\%Z5_95_=>1JA(DO)?L[,"Y`.S*@GY`=I!QR&KO
M++QOX7U!@MOKMB7/`2241L?H&P34U:=1R<K%0G%+EN;J2)*@>-U=3T*G(IU<
MYJ%%`#)98X(7FFD6.*-2SNYPJ@=23V%>>:_\8M"TQFATR.35)U.,H=D7_?9'
M/X`CWK6E2=1Z$3FH+4X.?XD^-_$]R]GI*&(L"?)L("SA,]2QR1U'(Q5^W^%/
MB[Q#-'<>(M4$("\&XF:YE7V`S@#_`(%76W3H+S.=<]7T-B?X9^"?"UBEUXCU
M>=\Y^^_EB0CJ%106/X$U6M_$WPHL5\J'0?-5>C2V@ES^,A)_.LU*M55XZ(NU
M.&CU.T\*^._#6N7HTG1XY+=UC+I$8!&I`QG&.*["N:I"4':1M&2DKH**@HI:
MKJ4>D:7<:A-#-+%;H9)%A4%@HZG!(Z#FJ_A_Q#I_B;2EU'39&:$L48.N&1AU
M!'Y'\15<KY>87,KV-6O(]<SXX^+]GHP+-INCC?.``5+#!?\`,[$/T-:4=&Y=
MD14U27<]2OM,L-3C\N_L;:[C'19XE<?D16!??#CPC?IMDT2WBQT-N3%C_ODB
MHC4G'9E2A&6Z,!_A%;6,C3>'=?U/29VX<J^Y6'I\NT_F34+)\4/#0RDMGX@L
MXSP&&)2G_CIS^+?C6_M85-*BU[F?)*'P%W2?BSI4]V;#7;2XT2^5MKI<`E`>
MV6P"OX@#WKOHI8YX4FAD62*10R.AR&!Z$'N*QJ4W!^1<)J1\W^/O'-[XJU26
M".5HM)A<K#`K<28/WV]2?3L/Q)O?#OX=-XJ)U+46>+2HWV@)PT[#J`>RCN?P
M'J.YM4:6AS+]Y,]YTS2=/T:S6TTZTBMH%_@C7&?<GJ3[FGZA>Q:=IMU?39\J
MVA>9\==J@D_RKSM9/4Z]$CR7P?X;E^(>I7'BOQ.SS6ID:.UM-V%(';C'R+G&
M.Y!)[Y]0B\.Z)!$L<6CZ>B+T5;9`!^E;5IM2Y8[(SIQ5N9[LEAT72[>YCN8-
M.M89X\[9(H55AD8(R!T]JJZWXIT/PXBMJVHQ6[-]V/EG(]0B@MCWQBLDI3=M
MRVU%7&Z'XMT'Q'N72M2BGD7K$04?'KM8`X]\8K3N[RUL+9[F\N(K>!/O22N%
M4?B:'"47RM:C4DU='-VGQ'\'ZC=?8XM9AWMD?OHWC0^VYE"_KS7)^"-_@_XC
M:KX3D+BRO,W%CDY'`)&/JN03ZQULH2C&49+I?[C)R3::/0O$FLQ^'_#E]JL@
M#?9XBR*3C<YX4?BQ`KSSX<2:?X7\+W/B?Q#>I!<:K*75Y6)>1%/91R26+$XS
MQ@TH)^S=NN@Y-<ZOT.KM_B9X1N89Y8M64B!-[JT+JQ7N5!4%L>V>*MW/CC0+
M31;76)+J4Z==9$=PEO(ZY!P0<+\ISD8..AJ71FG9HKVD6;5C?6NI6,-[9S+-
M;3('CD7H1_GM63IGC+0]:U6;3=-NWNKB$D2&.%S&N.,[\;<<<'//;-0H2=_(
M?,M/,M:WX<TGQ%:_9]4LH[A0/E<C#I_NL.17F`&J?"3Q#;1&YDO/#%])L_>'
MF(GJ?9@.>.&&>AZ;4I<R]FR*BL^='%^//!-[X4U:618FDTN9R;>=5^5<_P`#
M>C#I[]1W`]7^$>NV>H>#X-,C94O+#<LL7<J6)#CV.<?4'VK:L^>DI(SIKEJ6
M9Z!6%XTM9+SP5K4$)/F-9R%0.IPN<?CC'XUQPTDCHELS!^$%Y!<?#ZU@B=6D
MMI94E4=02Y<?HPK-U#X?^+-3U.[O?^$TN[19YW>.WBDEVQH6.U>'`X7'0?GU
MK?GC"I+F5S+E<H*SL<_IDVN^#OB?;:7?^(+W4K?[++-*LDKLK*(9'`VLQP04
M'(_J:O?#KPY8^*(;[Q=XE"7US)<,`L^#&@4#)*]#UP`>``*TFU&//%6ND1%7
M?+(P?&FH>"E:VU?P=>+::Q;SJWEV]O)&C#U`*A01QTP""<YK8OYV^)/CW2-(
MNI)8=+AL8KV6!6QN9XU<\^N'5?8;L8S3M))2GNKBNF^6.S.WU3X;>%]1TDV,
M6E6]HZKB*X@3;(IQP2W5_P#@6:\>B>^F\)0:TK;M0\,WR1>8?^>!(**2.H5P
M1CT>IHS<E[W]7*J147H==X]UP>-I_#7AW295VZCLNIB#N,>0<`X_NC>2/85!
MX0T"P\9^,=7N=2C,FG:0R6ME:%L*$!94!`[`)DCH2QSGFFKTZ?FOU8M)S.A^
M(G@'0I?"][J5C806-W90F96MHQ&KJO)5E'!XSSUZ=N*N?#BPM=4^$UA8WL*S
M6TZSI(C#@CSI/U]^U9.I)TKOHRU!*>G8\UU2^UWP%-JG@NTO8I+6[93!,TH#
M0JY]<@(2.#G&/O#&<U[)X-\*VOA+08[&':\[_/<S`?ZQ_P#`=`/ZDU59KE37
MVM14T^;7H=#7)^*M,3Q<]IHL85K6&Z6>]G(R(PHXC'J[9_X",D]5!P@[2OV-
M9*ZL=1<6\-U;R6]Q#'-#(I5XY%#*P/4$'J*X+4/A591ZBNI^&]0N-%OD;<IC
M^>/W&TG(!],XQQBG3J.'H*<%+U-2RU?Q5I:"+7]%%ZBC!O=)8/GTW1-ANG4K
MGZ5N6>NZ9?7(M8;M!=[=_P!EE!BF"^IC8!@/PHE%;QV!2>TCSG5/"'B+P7K=
MQK?@H+/9SG=/IQ&0.^`N1N`).,$,,X'&:G/Q/\1Q?+-X!U$..O\`K!_[2K?E
MA57,W9F=Y4]+71A:=>:EX@^+>EZW?Z!>Z=:^6T,@EB<H/W4B@EBHQDL!5J*R
M\4?#J;4--M='GUKP]>%VC$&3(F1CDJI*G&`<C!P",<U3Y;\C?3?T)7-\5NI4
M37;)$51\(,A1@;H"3^),/-;.OZ9K-[=Z9X\\,64D6H1PA+G3IX\.``01M.,\
M$C'!("D4G:+]Z5T]!K5:1L%UX^\::G;/8Z;X*OK.]D^07$JN5C)[_,BJ/8DX
M^M='X/\``\>A^"Y]&OV$LM^'-V4/`W+MVJ?8=_7)K.?+3C:+NV5&\W=JQS/P
MJ\$76C:WJM_J4$B26KM:6Y=-HDY^:1<]B-N"..33]2TCQ'X&\87VO>'M/;4]
M,U)M]S:1@EU8DGH,GJ200#C<01T)MU(RJ-/9B4'&*:W10\1>(_&OC+2)M,L?
M"=YI]NR,UP\BL6D5>=JEE7KC&!DGIZUL>%M;G\,?"FU0Z9?2ZI"9D2S%I(6W
MM([*6&.%P02?P'/%$H1Y%!/J)2ES<S70H:)\,9=>T&_U+Q,\RZYJ7[R)Y,[K
M;TRN>_&5/08'!K9\"7WBRPL9=#U;0[F5K(^5!>-(J1LHX`)/)`[,H;C&1QRI
MSC--=MAQBXM/ON=Y&LSQ_P"D;`S`96,G"^HW<9_(?2JMYJ6G:'#;QSNEO$Q$
M<:JF%'0`<<#MQ7,DV[(VO;5FA12&%,EABG39-$DB^CJ"*`(X;."W`$$8B0=$
M0E5'T4<5/0W<`I-P]1UQU[T``92"0P('7FD#H20&4D#)&>@H`7<HZD>O6C<N
MW=N&T<YSQ0`(ZR('1@RGD$'(-+0`4A('4]:`%HH`*J7VEV6I>7]MMTF$1W(&
M['UIIM.Z!JY;HI`%%`!10!%<S+;6LT[_`'8D+GZ`9KQV*UU2PT+P[+<WB7$'
MV:[UE8/)"F.41,ZL7SECOE!K>C:SO_6YG4N7;+P^\&IVWAB*(1VFHZ78S:@R
MD#]W%Y@E7CG+DH,CL6JT_P!J\06BZ?IT2N=:8ZE=K),8`MDI5(H@P5L;E500
M`?XQQG-:.2;O_7]:$):6_K^M3F;V_DO_``Y$\W[M;+1X-+<XR1(\VV1OIY<!
M/OG%:=Y'I;Z?J>IV]I)I7AF[DMH088D*AT8L9F@!P4.$4KU/7%7JM%_6Q.C-
M_2[BZLOA;JFI:9'!9S%YKF![9-L;J&X=8V+"/<JYV=`2>A-96N^+/$-M;6ZI
M=O;7E]"UW;Q@QX42.%BC_P!6V[8,,Q)7.XX)X`SC",I:]RW)I:%JY\3:UYFM
M+!J-P=4LOM+/:+#%Y$,2G;&Q)&XL00_!(R""!P*KZAXCNY+*"ZTZ_GU"!!<S
MVUQ>6\(?>$2&-EPHP/-FZD*<;@>.HH1["<F2:SKGB'1?MBOK3M90:A%;/>3)
M&K+_`*.'8`+&W#.RC[IQC\:ETOQ!XAF\2:-IM[J$GG21PFXME2-6(VL[2$[2
MK*1A2`RL""0".2<D'&]@YI7M<].HKE-S_]D`_^TO1%!H;W1O<VAO<"`S+C``
M.$))300$```````1'`(```(``!P"!0`%4')I;G0`.$))300E```````0UPI0
M%;\,*P7ZOCQ>"-2!`3A"24T#Z@`````8(#P_>&UL('9E<G-I;VX](C$N,"(@
M96YC;V1I;F<](E541BTX(C\^"CPA1$]#5%E012!P;&ES="!054),24,@(BTO
M+T%P<&QE+R]$5$0@4$Q)4U0@,2XP+R]%3B(@(FAT='`Z+R]W=W<N87!P;&4N
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M;G1E9V5R/C`\+VEN=&5G97(^"@D)"3PO9&EC=#X*"0D\+V%R<F%Y/@H)/"]D
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M:6YT+G1I8VME="YS=&%T949L86<\+VME>3X*"0D)"3QI;G1E9V5R/C`\+VEN
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M:V5Y/@H)"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"0D\+V1I8W0^"@D)
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M1FQA9SPO:V5Y/@H)"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"0D\+V1I
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M/@H)"3QS=')I;F<^,#`N,C`\+W-T<FEN9SX*"0D\:V5Y/F-O;2YA<'!L92YP
M<FEN="YT:6-K970N='EP93PO:V5Y/@H)"3QS=')I;F<^8V]M+F%P<&QE+G!R
M:6YT+E!A<&5R26YF;U1I8VME=#PO<W1R:6YG/@H)/"]D:6-T/@H)/&ME>3YC
M;VTN87!P;&4N<')I;G0N=&EC:V5T+D%0259E<G-I;VX\+VME>3X*"3QS=')I
M;F<^,#`N,C`\+W-T<FEN9SX*"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME
M="YT>7!E/"]K97D^"@D\<W1R:6YG/F-O;2YA<'!L92YP<FEN="Y086=E1F]R
M;6%T5&EC:V5T/"]S=')I;F<^"CPO9&EC=#X*/"]P;&ES=#X*.$))30/M````
M```0`2P````!``$!+`````$``3A"24T$)@``````#@`````````````_@```
M.$))300-```````$````'CA"24T$&0``````!````!XX0DE-`_,```````D`
M``````````$`.$))300*```````!```X0DE-)Q````````H``0`````````!
M.$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&````
M```!`#(````!`%H````&```````!`#4````!`"T````&```````!.$))30/X
M``````!P``#_____________________________`^@`````____________
M_________________P/H`````/____________________________\#Z```
M``#_____________________________`^@``#A"24T$"```````$`````$`
M``)````"0``````X0DE-!!X```````0`````.$))300:``````-;````!@``
M```````````""@``!=P````3`$<`90!O`%8`80!X`%\`;`!O`&<`;P!?`'0`
M80!G`&P`:0!N`&4````!``````````````````````````$`````````````
M!=P```(*``````````````````````$`````````````````````````$```
M``$```````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$`
M```$`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO
M;F<```(*`````%)G:'1L;VYG```%W`````9S;&EC97-6;$QS`````4]B:F,`
M```!```````%<VQI8V4````2````!W-L:6-E241L;VYG``````````=G<F]U
M<$E$;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-
M875T;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM
M9R`````&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N
M9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG```""@````!29VAT
M;&]N9P``!=P````#=7)L5$585`````$```````!N=6QL5$585`````$`````
M``!-<V=E5$585`````$```````9A;'1486=415A4`````0``````#F-E;&Q4
M97AT27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!
M;&EG;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R
M=$%L:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB
M9T-O;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90``
M``ET;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N9P`````````,
M8F]T=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X
M0DE-!"@```````P````!/_`````````X0DE-!!0```````0````".$))300,
M`````!$O`````0```*`````X```!X```:0```!$3`!@``?_8_^``$$I&248`
M`0(``$@`2```_^T`#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`A``,
M"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,
M#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``X
M`*`#`2(``A$!`Q$!_]T`!``*_\0!/P```04!`0$!`0$``````````P`!`@0%
M!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%
M!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<E
MDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D
M]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'
M!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q
M)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#U5),YS6M+
MG$-:T22=``%R76/\9?0L$NJP0[J=[=)I(;2"/WLIWL=_Z#LR$Z,92T`M!(&Y
M>N3$@"3H!R5Y/D?7_P"M_5LC[+TUHH>Z=M&'4;KMO\NRUMO_`&ZVFA&I^H/U
MPZT6V=9RC2R>,NUV38!_)QZW_9V_]OJ3V:^>0C^)6^Y?R@E[_+^M/U<PI&3U
M+&8YO+!:US_^VJRZS_HK*R/\97U4I$UWVY'_`!5-G_57-I9_TECO_P`7WU3Z
M'C#*ZYU&STP8,N;CUN/[E=5+?M#W_P`AESWH='6/\4^$\MJPVVQ^?;C6W?<<
MQK[$A"!V$Y^0T092Z\,6W;_C<Z&-,?#RK7=@[TF_]3=8_P#Z"C7_`(RNIY&N
M)]7,J\=B#8?_`#UB6K:^KWUK^JW4LD]/Z015=L-@J]$T@M;&_9[&L=LW?171
M($PCH<9_PB4@2/Z7V!X;_GM]<;#^A^JUS?ZYL'_5X]*<?6C_`!A.^C]6@!YV
M1_U3FKN$D../[@_YR>$_O%XD?67_`!B#4_5II'E:W_THI#ZV_7=G\[]5GN'\
MB[_R++5U74NH5=-PK<ZYEEE-`WVBIN]P:/IV;/I.;6WWOVJ'1^L8'6L%F?T^
MSU*'DMU!:YKFG:]CV.]S7)<0J_;%?X2JZ<1>8_Y]_6)I_3?53-`'.PO?_P"Z
MK57ZW]?;+?JWU!S<'+Z5E'9C5/R&EAW7![K74.]MGJ8^+5==NV^Q_HKO%Y[U
MJ/K1_C`Q.D#WX'2`;,G@@N&R[(:?Z]GV/#_]B4Z'`3\M</J.IZ(E8&]WHO\`
M53K_`-4_JMA_LK/R!C]5]K\\^F]\6/`L;C.MJ9;_`$.M[<=[?\':RW\_>NMQ
M/K3]7,V!C=2QGN=PPVM:_P#[:L+;/^BK>3TWIV6(R\6G(!Y%M;7_`/5M<LC,
M^H/U1S)-G3:ZR>])=3_T:'5L_P"BFF4)&Y<0)WZIJ0T%4[X((D:@\%.N)=_B
MT;ADOZ#UC-Z8[G;NWL^&RHXSO^W'V*+K?\9W1/=8S'Z_C-Y+`&W!H\FC'?O_
M`.M9B7`#\LQ_A>E7$1N#]-7N$ER72O\`&1T3*N^R=399TC,:=KZ\D0P._===
M#/2_]"J\9=8US7-#FD.:X2"-004R491W%)!!V?_0I?7'ZV9G7,R[%KL+.DU/
M+*J6D@7;#'VC(_TK7N;OIJ=^C8S9_A5/ZG?4R[ZP/=E9+G8_2Z7%A>S2RUX^
ME51/\W77_AK_`/K-/Z3U+*:7UH^KN5T#J5E5C#]BM>3A9'YKF$ES*'._-R*6
M^S9_A/YUB]"_Q;=0Q<GZM4X=1`R,!SZ\BON"][[J[8_<O8[=O_TGK?Z-6YRX
M<0,-N[!$7/U._P!-Z5TWI6.,;IV.S&J'(8-7']^QY]]K_P#A+';T7+R:</%N
MR[SMIQZW6V.YAK`7O/\`FM1ED?6VFV_ZL=4JJDO=BVD`<F&EQ9_;C:JHUD+.
MY9MAH\;]7>B7?7;.N^L?7RXX0>:L3##B!`^E7O;MVX]/\V_TO?EY7J^K^CK]
M.SMV?5OZNUL#&=+Q`T:`>A7_`.065_BWR:+_`*I8K*G`NH?;7:!V=ZC[O^G7
M;7;_`-<6=F?5S_&#EYF1DU];;BU6VO=3CM+@&5;CZ%?Z.O9N;3LW_P#?U+(D
MR(XN`1T`6C2(-<1.[U5'0^C8V17DXV#1CWU3LLJK;6X!PV/;NJ#=S7?NN3]2
MZSTKI3&OZCEU8H?.P6.`+HY]-GTW_P!A<)T[-^LO0_KA1TSJ_4WYU+L>R^YH
M.YA8*K[F;18UKF6L?B_FJ7U-^K^-]:&Y'UH^L7ZW9DV.;30XD5M:SF8=[F5N
M_04TN_1,KK]7]);:@<=:RE<:&W7B4)7H!1\7N.F]<Z/U4._9V93E%@E[*W@N
M:/%]?\XS_-5JZ^G'J==?8VJJL;GV/(:UH'YSGN]K5Y3]9+/JEB.IZM]3\QM'
M4\2P'T:?4V/;]%SJ][?3V_Z5C'_9\C&]7^0M3JEMOUU^L^#T9SW4=,IQ*\[(
MK:=2;&,NG]USVMR,>BIW^!WY%J)Q;'41U)XAZAPJX^FA/@]=C_6SZL9E_P!D
MIZEC66O.P,+Q#R?;L9O]EN[^0N9^IQ=]7?K9U+ZK6$C&R#]HZ?),&!N:UNGN
M<[$_1O=_YK[%K=0_Q<_5?*P7XU&*,2W;%62PN<YKNSK18\_:6_OLN_\`4BX/
M[1U)_1\?K,E_4_JOF-Q;7F3NQW$.QVVVEVY_HY7JX?\`X6R$81B1(1)HZ>K]
M[]"2)$@B^G;\7U?K74ZND]*RNI6ZMQJR\-XW/^C55_UVTLJ7'_4`8O2NC9/U
MCZUDUT6]5N<?7N<&[FM+S[=WNWY&0[)NV,_G*_20OKSU0]?/1.@]+<8ZOZ>6
MY\&14^?L[GM'YM?ZQE6M_P"Z:K]!Z)B?6GZP9UN<"[I/1",'`P@YP;LKW45-
M+MWJ;?3H]:[_`$]MOO\`T-'I)1B!C/%I>LN_"-@HFY:=-O-["CZX_5C(JMMI
MZA58*&FRUHW;PQNK[/0V^L^NO_"/97^C1,CZU_5_&PL?J%V8T867I1DM:]U;
MB)_1^I6QS&6^Q_Z*S]+['KG?KA]1>BMZ/D=0Z9CMP\K!K=?%<M8]E8WVUOK^
MAO\`2W^G8SW^I_P:N?4G`Q.H_4+'PLRL6X^1]H;8P^!R+_<W]U['>^M_^#L3
M3''PB0XJNB$W*Z-;6]1CWTY-%>1CO;;3<T/KL:9:YKAN:YKOY2H8GUEZ)F]0
M?TW#RAD9=6[U&5M>X-VG:_?:UGHL;O\`9_.?37G5^;]8_JD,SZI4O]7[66'I
MN2'ACF,O>ZMSZI]M+\AV^MVY]/V3+];+K_1O7>_5/ZM8_P!7>E,Q6[7Y5D/R
M[F_G/B-K-WN]"EOZ.AO_`%S^=LL0EC$19-W\E?F4B1)KMNV>L_5[I'6Z?2ZC
MCMM(!%=P]MK)_P!%<W](S^K_`#?^D7%4.ZM]0.L8^%?<[+^K>;9LJ>__``6X
M^[1O\Q;3N]6VNO\`5\JCU;JJJ[_47HZYOZT8=?U@MQNA5-+VU9%>3GW`>VFI
M@+O1]3_N9EM?Z==7YE%C\BWV>CZRA+]$ZPZ^'BJ0ZC=__]'U#*Q<;,QWXV74
MR^BT1958T.:X<^YKEQ^1_B[LP<O]H_5;J#^FY300VFV;:BTQ^A+W?I?1=M^A
M=]J_D;%VJ2=&<H['Z=$$`[O/8WU@ZSA@5_6'I5M1&GVWIX=E8[H$EYIIWY^,
MW_C,>S_C5KX/5.F]187X.35DAOTA6\.+?*Q@]U;OY+U:5?(Z?@Y3@_(QZ[7M
M^B][07-_J/(W,_LI$@]*\E:O"9?1/K!]3>J6]2^K=)SNDY)F_``+G,U_F_39
M^E<RO=^JY%#;+*J_T.13;77ZJ,W_`!LX31MR.EY5=HT>P%A`/_7#2_\`\#7<
M58[*M&.?'@Y[G_\`GTO14[W(GYH\1[WPGZHX3T->&[Y;A]>P>O\`^,/I^?Z3
ML>BRIV,:[]HEWI93=OL+F?I?6]-GN1L:_J_U#.7TK.Q+LWH.0YQHRZ/I-#QL
MG>6^DRW8W]+1?Z/Z;]-3ZC+%Z8DB<HVX?30'#?[OB@0/?6[M\H9U_P#Q<5UM
MK;]7+G!@#1N;6XD`1[G.R?=_:6IU.O*?E8'UZ^J=)R*32VG*P6M(>&MFK8ZB
MK=]!OZO=73O]"RC'NJKOJ]1>AI)'*-P#X\4N+17!W(^@I\_O_P`9F5G4?9.B
M])R3U2P%L.;O;6?WVLKW/MV?\,S&K_TJUOJM]3Q@_5G(Z;U3WY'5-[LT`AQ;
MO;Z3:Q9^=94P;_4_[D^IZ:ZI)-,Q51'#U.MI$=;)M\Z_Q;_5W(IZKG9N>V;.
MF.=T^F=1Z@UR+:]WT:_2]+T?Y&3:IYE?6?J3]8,WJF'B/S^B=3=ZN0RL2ZMQ
M+K#.QKO1].VVWTG[/L]E-GHV/KLKK>O0DD3E)D218(HQ5P`"ATZOFW6OKKU'
MZS8%_3.@],R158P_;+W"7"H`ONJ9Z1=4WU6-]/W7>K;_`#-%'K6*Y]6OK5TO
MH?U!QLBZQMN0QV0VK$:X"Q]ANNM97MU=6W8]EEEKF?HZOTB[U)(Y(UP\-"^+
M='";N]:K9\WZ5]1\KZP]*S>L=:L+>J=5_28A=N`K`_FW6U?Z*]FVGT/\#@^G
M_P!J%K?5#KW7VX[ND=6Z7FW9F$XTC*#6ACFMX];*R+**K;&?Z:IUOVFKT[OY
MQ=DDD<ID""`>W]5(C6W^^BK]:RL^NT5EWYK'$D#_`(R&?]!"?D=/Z<RNE[F8
M[7D[&\"29>[_`#G?I+'*TJN9TW%S',?<#-?$&)!['_R;?TC/TFS^<3!779+_
M`/_2]527RJDDI^JDE\JI)*?JI)?*J22GZGML934^VPPRMI<X\Z`;G+SRC*^L
M6+@])NS]MV/Z>7UU[:S:+_T=5N773EO+_3<S[3GX]?H[/\&O&TE)CK7;Z^71
M;)]LQ\3JK,C'^KH=D-LZET[IYS<G<\BIE)ROVNYMK]^S)ROT.*S;_P!R/6_P
M**[)R\VAU6#5D66==M.1;]G+6/JZ53&)B_9[,J['IILZA776^OW[_P!<S+O\
M"O#DD[[.G\C_`,Q#Z_D=2ZGD='HL]6RCT.CX^):]WJ;FY&;D-PLJ]S6CU/5Q
ML;I^1=O^G[U:R#0W%ZA^S[\S"Z#DG%IJRLG[2^GUFNNR,M[W6VUYV/TG*K;C
M=/RLNM]-?K6_3]+U5XLDG:=._3^7S(_@^\]-RLW$^I6;G]/J=C6U.LNH98Y^
M13Z=19ZEO3VWBO(^P9-55E^-4_\`TOZ/]'Z:!U/ZS]<IQ_48749%['YF'C&E
MH)J?8S%Z=B/]2RVVVW;^M]3KII];'^U?S^+Z/Z;PU)-'#>M;G?LG6M+V?><G
MZQ=98_J=^/:RS(P?M+1T<XUCBVNIWI8F7=DUEEE?VC^G;?H9F'^AP_TU3\A5
M\_K><,2NVC*;U;[,,O+IRQCOJ:ZRBJO%Q:Z6U.]+,KLZCU*OT[JM]'I5OK_2
M6T_:%X<DD.'3;\.RC;[ME=;^L6$<BC)RZO09FLQG]1])M3:FC%;FY`9ZKK:&
M^KD/JQL1^1ZOZ3U*?TMWHHF+U_KEG5.F8F5:RNRZNG[1C4TN+I<VRV^^^G*;
MC9->(^OT?2S,=_IX&9ZN)G46V+P5)+TU^C==*5KXOU4DOE5)0KW_V0`X0DE-
M!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O
M`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``0P!3`#,`
M```!`#A"24T$!@``````!P`(`````0$`_^$YL6AT='`Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#
M96AI2'IR95-Z3E1C>FMC.60B/SX-"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O
M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#0N,2UC,#,V
M(#0V+C(W-C<R,"P@36]N($9E8B`Q.2`R,#`W(#(R.C$S.C0S("`@("`@("`B
M/@T*"3QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY
M.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^#0H)"3QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE
M;65N=',O,2XQ+R(@>&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O(B!X;6QN<SIX87!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+VUM+R(@>&UL;G,Z<W12968](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.FEL;'5S=')A=&]R/2)H
M='1P.B\O;G,N861O8F4N8V]M+VEL;'5S=')A=&]R+S$N,"\B('AM;&YS.GAA
M<%109STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+W0O<&<O(B!X;6QN
M<SIS=$1I;3TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+T1I
M;65N<VEO;G,C(B!X;6QN<SIX87!'/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O9R\B('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]P:&]T;W-H;W`O,2XP+R(@>&UL;G,Z=&EF9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]T:69F+S$N,"\B('AM;&YS.F5X:68](FAT='`Z+R]N<RYA9&]B92YC
M;VTO97AI9B\Q+C`O(B!D8SIF;W)M870](FEM86=E+VIP96<B('AA<#I#<F5A
M=&]R5&]O;#TB061O8F4@4&AO=&]S:&]P($-3,R!-86-I;G1O<V@B('AA<#I#
M<F5A=&5$871E/2(R,#$S+3`U+3`R5#(Q.C(X.C0U+3`T.C`P(B!X87`Z36]D
M:69Y1&%T93TB,C`Q,RTP-2TP,E0R,3HR.#HT-2TP-#HP,"(@>&%P.DUE=&%D
M871A1&%T93TB,C`Q,RTP-2TP,E0R,3HR.#HT-2TP-#HP,"(@>&%P34TZ1&]C
M=6UE;G1)1#TB=75I9#I!,#DW,T8X.#`Q0C5%,C$Q.3(Q.44R0CDP1C4T-#9#
M.2(@>&%P34TZ26YS=&%N8V5)1#TB=75I9#I!,3DW,T8X.#`Q0C5%,C$Q.3(Q
M.44R0CDP1C4T-#9#.2(@:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4](E!R
M:6YT(B!X87!44&<Z3E!A9V5S/2(Q(B!X87!44&<Z2&%S5FES:6)L951R86YS
M<&%R96YC>3TB1F%L<V4B('AA<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/2)&
M86QS92(@<&AO=&]S:&]P.D-O;&]R36]D93TB,R(@<&AO=&]S:&]P.DE#0U!R
M;V9I;&4](G-21T(@245#-C$Y-C8M,BXQ(B!P:&]T;W-H;W`Z2&ES=&]R>3TB
M(B!T:69F.D]R:65N=&%T:6]N/2(Q(B!T:69F.EA297-O;'5T:6]N/2(S,#`P
M,#`P+S$P,#`P(B!T:69F.EE297-O;'5T:6]N/2(S,#`P,#`P+S$P,#`P(B!T
M:69F.E)E<V]L=71I;VY5;FET/2(R(B!T:69F.DYA=&EV941I9V5S=#TB,C4V
M+#(U-RPR-3@L,C4Y+#(V,BPR-S0L,C<W+#(X-"PU,S`L-3,Q+#(X,BPR.#,L
M,CDV+#,P,2PS,3@L,S$Y+#4R.2PU,S(L,S`V+#(W,"PR-S$L,C<R+#,P-2PS
M,34L,S,T,S([14,R,T8S1#(R1$)$1C$T-40T1C(T,C=&030Y-D0P0S(B(&5X
M:68Z4&EX96Q81&EM96YS:6]N/2(Q-3`P(B!E>&EF.E!I>&5L641I;65N<VEO
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M,"PT,3DY,2PT,3DY,BPT,3DY,RPT,3DY-"PT,3DY-2PT,3DY-BPT,C`Q-BPP
M+#(L-"PU+#8L-RPX+#DL,3`L,3$L,3(L,3,L,30L,34L,38L,3<L,3@L,C`L
M,C(L,C,L,C0L,C4L,C8L,C<L,C@L,S`[-D)%0T0T-3!#0T(T-3(S1$$Q040P
M.4%%,39"0D0Y.#0B/@T*"0D)/&1C.G1I=&QE/@T*"0D)"3QR9&8Z06QT/@T*
M"0D)"0D\<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/E!R:6YT/"]R9&8Z
M;&D^#0H)"0D)/"]R9&8Z06QT/@T*"0D)/"]D8SIT:71L93X-"@D)"3QX87!-
M33I$97)I=F5D1G)O;2!S=%)E9CII;G-T86YC94E$/2)U=6ED.CE%-3$W0S8T
M,#%"-44R,3$Y,C%%1#-!0D9"-S0T.3$U(B!S=%)E9CID;V-U;65N=$E$/2)U
M=6ED.CE$-3$W0S8T,#%"-44R,3$Y,C%%1#-!0D9"-S0T.3$U(B\^#0H)"0D\
M>&%P5%!G.DUA>%!A9V53:7IE('-T1&EM.G<](C@N-3`P,#`P(B!S=$1I;3IH
M/2(Q,2XP,#`P,#`B('-T1&EM.G5N:70](DEN8VAE<R(O/@T*"0D)/'AA<%10
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M(E!23T-%4U,B('AA<$<Z8WEA;CTB,"XP,#`P,#`B('AA<$<Z;6%G96YT83TB
M,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(P+C`P,#`P,"(@>&%P1SIB;&%C:STB
M,"XP,#`P,#`B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE
M/2)";&%C:R(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B
M('AA<$<Z8WEA;CTB,"XP,#`P,#`B('AA<$<Z;6%G96YT83TB,"XP,#`P,#`B
M('AA<$<Z>65L;&]W/2(P+C`P,#`P,"(@>&%P1SIB;&%C:STB,3`P+C`P,#`P
M,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D--64L@
M4F5D(B!X87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P
M1SIC>6%N/2(P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(Q,#`N,#`P,#`P(B!X
M87!'.GEE;&QO=STB,3`P+C`P,#`P,"(@>&%P1SIB;&%C:STB,"XP,#`P,#`B
M+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#35E+(%EE
M;&QO=R(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA
M<$<Z8WEA;CTB,"XP,#`P,#`B('AA<$<Z;6%G96YT83TB,"XP,#`P,#`B('AA
M<$<Z>65L;&]W/2(Q,#`N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O
M/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D--64L@1W)E
M96XB('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#15-3(B!X87!'
M.F-Y86X](C$P,"XP,#`P,#`B('AA<$<Z;6%G96YT83TB,"XP,#`P,#`B('AA
M<$<Z>65L;&]W/2(Q,#`N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O
M/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D--64L@0WEA
M;B(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z
M8WEA;CTB,3`P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(P+C`P,#`P,"(@>&%P
M1SIY96QL;W<](C`N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O/@T*
M"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D--64L@0FQU92(@
M>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z8WEA
M;CTB,3`P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(Q,#`N,#`P,#`P(B!X87!'
M.GEE;&QO=STB,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)
M"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0TU92R!-86=E;G1A
M(B!X87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC
M>6%N/2(P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(Q,#`N,#`P,#`P(B!X87!'
M.GEE;&QO=STB,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)
M"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STQ-2!-/3$P,"!9
M/3DP($L],3`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#15-3
M(B!X87!'.F-Y86X](C$T+CDY.3DY."(@>&%P1SIM86=E;G1A/2(Q,#`N,#`P
M,#`P(B!X87!'.GEE;&QO=STB.3`N,#`P,#`P(B!X87!'.F)L86-K/2(Q,"XP
M,#`P,#(B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#
M/3`@33TY,"!9/3@U($L],"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4]
M(E!23T-%4U,B('AA<$<Z8WEA;CTB,"XP,#`P,#`B('AA<$<Z;6%G96YT83TB
M.3`N,#`P,#`P(B!X87!'.GEE;&QO=STB.#4N,#`P,#`P(B!X87!'.F)L86-K
M/2(P+C`P,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA
M;64](D,],"!-/3@P(%D].34@2STP(B!X87!'.FUO9&4](D--64LB('AA<$<Z
M='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(P+C`P,#`P,"(@>&%P1SIM86=E
M;G1A/2(X,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(Y-2XP,#`P,#`B('AA<$<Z
M8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A
M=&-H3F%M93TB0STP($T]-3`@63TQ,#`@2STP(B!X87!'.FUO9&4](D--64LB
M('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(P+C`P,#`P,"(@>&%P
M1SIM86=E;G1A/2(U,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(Q,#`N,#`P,#`P
M(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X
M87!'.G-W871C:$YA;64](D,],"!-/3,U(%D].#4@2STP(B!X87!'.FUO9&4]
M(D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(P+C`P,#`P
M,"(@>&%P1SIM86=E;G1A/2(S-2XP,#`P,#0B('AA<$<Z>65L;&]W/2(X-2XP
M,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\<F1F
M.FQI('AA<$<Z<W=A=&-H3F%M93TB0STU($T],"!9/3DP($L],"(@>&%P1SIM
M;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z8WEA;CTB-2XP
M,#`P,#$B('AA<$<Z;6%G96YT83TB,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(Y
M,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\
M<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STR,"!-/3`@63TQ,#`@2STP(B!X
M87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N
M/2(Q.2XY.3DY.3@B('AA<$<Z;6%G96YT83TB,"XP,#`P,#`B('AA<$<Z>65L
M;&]W/2(Q,#`N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O/@T*"0D)
M"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,]-3`@33TP(%D],3`P
M($L],"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA
M<$<Z8WEA;CTB-3`N,#`P,#`P(B!X87!'.FUA9V5N=&$](C`N,#`P,#`P(B!X
M87!'.GEE;&QO=STB,3`P+C`P,#`P,"(@>&%P1SIB;&%C:STB,"XP,#`P,#`B
M+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#/3<U($T]
M,"!9/3$P,"!+/3`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#
M15-3(B!X87!'.F-Y86X](C<U+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(P+C`P
M,#`P,"(@>&%P1SIY96QL;W<](C$P,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N
M,#`P,#`P(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB
M0STX-2!-/3$P(%D],3`P($L],3`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT
M>7!E/2)04D]#15-3(B!X87!'.F-Y86X](C@U+C`P,#`P,"(@>&%P1SIM86=E
M;G1A/2(Q,"XP,#`P,#(B('AA<$<Z>65L;&]W/2(Q,#`N,#`P,#`P(B!X87!'
M.F)L86-K/2(Q,"XP,#`P,#(B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS
M=V%T8VA.86UE/2)#/3DP($T],S`@63TY-2!+/3,P(B!X87!'.FUO9&4](D--
M64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(Y,"XP,#`P,#`B
M('AA<$<Z;6%G96YT83TB,S`N,#`P,#`R(B!X87!'.GEE;&QO=STB.34N,#`P
M,#`P(B!X87!'.F)L86-K/2(S,"XP,#`P,#(B+SX-"@D)"0D)"0D)"3QR9&8Z
M;&D@>&%P1SIS=V%T8VA.86UE/2)#/3<U($T],"!9/3<U($L],"(@>&%P1SIM
M;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z8WEA;CTB-S4N
M,#`P,#`P(B!X87!'.FUA9V5N=&$](C`N,#`P,#`P(B!X87!'.GEE;&QO=STB
M-S4N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O/@T*"0D)"0D)"0D)
M/')D9CIL:2!X87!'.G-W871C:$YA;64](D,].#`@33TQ,"!9/30U($L],"(@
M>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z8WEA
M;CTB.#`N,#`P,#`P(B!X87!'.FUA9V5N=&$](C$P+C`P,#`P,B(@>&%P1SIY
M96QL;W<](C0U+C`P,#`P,"(@>&%P1SIB;&%C:STB,"XP,#`P,#`B+SX-"@D)
M"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#/3<P($T],34@63TP
M($L],"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA
M<$<Z8WEA;CTB-S`N,#`P,#`P(B!X87!'.FUA9V5N=&$](C$T+CDY.3DY."(@
M>&%P1SIY96QL;W<](C`N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O
M/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,].#4@33TU
M,"!9/3`@2STP(B!X87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T53
M4R(@>&%P1SIC>6%N/2(X-2XP,#`P,#`B('AA<$<Z;6%G96YT83TB-3`N,#`P
M,#`P(B!X87!'.GEE;&QO=STB,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P
M,#`P(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STQ
M,#`@33TY-2!9/34@2STP(B!X87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB
M4%)/0T534R(@>&%P1SIC>6%N/2(Q,#`N,#`P,#`P(B!X87!'.FUA9V5N=&$]
M(CDU+C`P,#`P,"(@>&%P1SIY96QL;W<](C4N,#`P,#`Q(B!X87!'.F)L86-K
M/2(P+C`P,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA
M;64](D,],3`P($T],3`P(%D],C4@2STR-2(@>&%P1SIM;V1E/2)#35E+(B!X
M87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z8WEA;CTB,3`P+C`P,#`P,"(@>&%P
M1SIM86=E;G1A/2(Q,#`N,#`P,#`P(B!X87!'.GEE;&QO=STB,C4N,#`P,#`P
M(B!X87!'.F)L86-K/2(R-2XP,#`P,#`B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@
M>&%P1SIS=V%T8VA.86UE/2)#/3<U($T],3`P(%D],"!+/3`B('AA<$<Z;6]D
M93TB0TU92R(@>&%P1SIT>7!E/2)04D]#15-3(B!X87!'.F-Y86X](C<U+C`P
M,#`P,"(@>&%P1SIM86=E;G1A/2(Q,#`N,#`P,#`P(B!X87!'.GEE;&QO=STB
M,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\
M<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STU,"!-/3$P,"!9/3`@2STP(B!X
M87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N
M/2(U,"XP,#`P,#`B('AA<$<Z;6%G96YT83TB,3`P+C`P,#`P,"(@>&%P1SIY
M96QL;W<](C`N,#`P,#`P(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O/@T*"0D)
M"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,],S4@33TQ,#`@63TS
M-2!+/3$P(B!X87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@
M>&%P1SIC>6%N/2(S-2XP,#`P,#0B('AA<$<Z;6%G96YT83TB,3`P+C`P,#`P
M,"(@>&%P1SIY96QL;W<](C,U+C`P,#`P-"(@>&%P1SIB;&%C:STB,3`N,#`P
M,#`R(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STQ
M,"!-/3$P,"!9/34P($L],"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4]
M(E!23T-%4U,B('AA<$<Z8WEA;CTB,3`N,#`P,#`R(B!X87!'.FUA9V5N=&$]
M(C$P,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(U,"XP,#`P,#`B('AA<$<Z8FQA
M8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H
M3F%M93TB0STP($T].34@63TR,"!+/3`B('AA<$<Z;6]D93TB0TU92R(@>&%P
M1SIT>7!E/2)04D]#15-3(B!X87!'.F-Y86X](C`N,#`P,#`P(B!X87!'.FUA
M9V5N=&$](CDU+C`P,#`P,"(@>&%P1SIY96QL;W<](C$Y+CDY.3DY."(@>&%P
M1SIB;&%C:STB,"XP,#`P,#`B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS
M=V%T8VA.86UE/2)#/3(U($T],C4@63TT,"!+/3`B('AA<$<Z;6]D93TB0TU9
M2R(@>&%P1SIT>7!E/2)04D]#15-3(B!X87!'.F-Y86X](C(U+C`P,#`P,"(@
M>&%P1SIM86=E;G1A/2(R-2XP,#`P,#`B('AA<$<Z>65L;&]W/2(S.2XY.3DY
M.38B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\<F1F.FQI
M('AA<$<Z<W=A=&-H3F%M93TB0STT,"!-/30U(%D]-3`@2STU(B!X87!'.FUO
M9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(S.2XY
M.3DY.38B('AA<$<Z;6%G96YT83TB-#4N,#`P,#`P(B!X87!'.GEE;&QO=STB
M-3`N,#`P,#`P(B!X87!'.F)L86-K/2(U+C`P,#`P,2(O/@T*"0D)"0D)"0D)
M/')D9CIL:2!X87!'.G-W871C:$YA;64](D,]-3`@33TU,"!9/38P($L],C4B
M('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#15-3(B!X87!'.F-Y
M86X](C4P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(U,"XP,#`P,#`B('AA<$<Z
M>65L;&]W/2(V,"XP,#`P,#0B('AA<$<Z8FQA8VL](C(U+C`P,#`P,"(O/@T*
M"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,]-34@33TV,"!9
M/38U($L]-#`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#15-3
M(B!X87!'.F-Y86X](C4U+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(V,"XP,#`P
M,#0B('AA<$<Z>65L;&]W/2(V-2XP,#`P,#`B('AA<$<Z8FQA8VL](C,Y+CDY
M.3DY-B(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,]
M,C4@33TT,"!9/38U($L],"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4]
M(E!23T-%4U,B('AA<$<Z8WEA;CTB,C4N,#`P,#`P(B!X87!'.FUA9V5N=&$]
M(C,Y+CDY.3DY-B(@>&%P1SIY96QL;W<](C8U+C`P,#`P,"(@>&%P1SIB;&%C
M:STB,"XP,#`P,#`B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.
M86UE/2)#/3,P($T]-3`@63TW-2!+/3$P(B!X87!'.FUO9&4](D--64LB('AA
M<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(S,"XP,#`P,#(B('AA<$<Z
M;6%G96YT83TB-3`N,#`P,#`P(B!X87!'.GEE;&QO=STB-S4N,#`P,#`P(B!X
M87!'.F)L86-K/2(Q,"XP,#`P,#(B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P
M1SIS=V%T8VA.86UE/2)#/3,U($T]-C`@63TX,"!+/3(U(B!X87!'.FUO9&4]
M(D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(S-2XP,#`P
M,#0B('AA<$<Z;6%G96YT83TB-C`N,#`P,#`T(B!X87!'.GEE;&QO=STB.#`N
M,#`P,#`P(B!X87!'.F)L86-K/2(R-2XP,#`P,#`B+SX-"@D)"0D)"0D)"3QR
M9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#/30P($T]-C4@63TY,"!+/3,U(B!X
M87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N
M/2(S.2XY.3DY.38B('AA<$<Z;6%G96YT83TB-C4N,#`P,#`P(B!X87!'.GEE
M;&QO=STB.3`N,#`P,#`P(B!X87!'.F)L86-K/2(S-2XP,#`P,#0B+SX-"@D)
M"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#/30P($T]-S`@63TQ
M,#`@2STU,"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4](E!23T-%4U,B
M('AA<$<Z8WEA;CTB,SDN.3DY.3DV(B!X87!'.FUA9V5N=&$](C<P+C`P,#`P
M,"(@>&%P1SIY96QL;W<](C$P,"XP,#`P,#`B('AA<$<Z8FQA8VL](C4P+C`P
M,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,]
M-3`@33TW,"!9/3@P($L]-S`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E
M/2)04D]#15-3(B!X87!'.F-Y86X](C4P+C`P,#`P,"(@>&%P1SIM86=E;G1A
M/2(W,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(X,"XP,#`P,#`B('AA<$<Z8FQA
M8VL](C<P+C`P,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C
M:$YA;64](E!!3E1/3D4@-C0W($-652(@>&%P1SIT>7!E/2)34$]4(B!X87!'
M.G1I;G0](C$P,"XP,#`P,#`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIC>6%N
M/2(Q,#`N,#`P,#`P(B!X87!'.FUA9V5N=&$](C@V+C8V.3DY."(@>&%P1SIY
M96QL;W<](C,V+C@U.3DY-R(@>&%P1SIB;&%C:STB,3$N-S4Y.3DY(B\^#0H)
M"0D)"0D)"3PO<F1F.E-E<3X-"@D)"0D)"0D\+WAA<$<Z0V]L;W)A;G1S/@T*
M"0D)"0D)/"]R9&8Z1&5S8W)I<'1I;VX^#0H)"0D)"3PO<F1F.FQI/@T*"0D)
M"0D\<F1F.FQI/@T*"0D)"0D)/')D9CI$97-C<FEP=&EO;B!X87!'.F=R;W5P
M3F%M93TB4')I;G0@0V]L;W(@1W)O=7`B('AA<$<Z9W)O=7!4>7!E/2(Q(CX-
M"@D)"0D)"0D\>&%P1SI#;VQO<F%N=',^#0H)"0D)"0D)"3QR9&8Z4V5Q/@T*
M"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA;64](D,],"!-/3,P(%D]
M-S`@2STP(B!X87!'.FUO9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@
M>&%P1SIC>6%N/2(P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(S,"XP,#`P,#(B
M('AA<$<Z>65L;&]W/2(W,"XP,#`P,#`B('AA<$<Z8FQA8VL](C`N,#`P,#`P
M(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STU($T]
M-S`@63TY,"!+/3`B('AA<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#
M15-3(B!X87!'.F-Y86X](C4N,#`P,#`Q(B!X87!'.FUA9V5N=&$](C<P+C`P
M,#`P,"(@>&%P1SIY96QL;W<](CDP+C`P,#`P,"(@>&%P1SIB;&%C:STB,"XP
M,#`P,#`B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P1SIS=V%T8VA.86UE/2)#
M/34@33TY,"!9/3<U($L],"(@>&%P1SIM;V1E/2)#35E+(B!X87!'.G1Y<&4]
M(E!23T-%4U,B('AA<$<Z8WEA;CTB-2XP,#`P,#$B('AA<$<Z;6%G96YT83TB
M.3`N,#`P,#`P(B!X87!'.GEE;&QO=STB-S4N,#`P,#`P(B!X87!'.F)L86-K
M/2(P+C`P,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL:2!X87!'.G-W871C:$YA
M;64](D,],S`@33TP(%D].34@2STP(B!X87!'.FUO9&4](D--64LB('AA<$<Z
M='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(S,"XP,#`P,#(B('AA<$<Z;6%G
M96YT83TB,"XP,#`P,#`B('AA<$<Z>65L;&]W/2(Y-2XP,#`P,#`B('AA<$<Z
M8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\<F1F.FQI('AA<$<Z<W=A
M=&-H3F%M93TB0STV,"!-/34@63TY-2!+/3`B('AA<$<Z;6]D93TB0TU92R(@
M>&%P1SIT>7!E/2)04D]#15-3(B!X87!'.F-Y86X](C8P+C`P,#`P-"(@>&%P
M1SIM86=E;G1A/2(U+C`P,#`P,2(@>&%P1SIY96QL;W<](CDU+C`P,#`P,"(@
M>&%P1SIB;&%C:STB,"XP,#`P,#`B+SX-"@D)"0D)"0D)"3QR9&8Z;&D@>&%P
M1SIS=V%T8VA.86UE/2)#/3,P($T],"!9/3$P($L],"(@>&%P1SIM;V1E/2)#
M35E+(B!X87!'.G1Y<&4](E!23T-%4U,B('AA<$<Z8WEA;CTB,S`N,#`P,#`R
M(B!X87!'.FUA9V5N=&$](C`N,#`P,#`P(B!X87!'.GEE;&QO=STB,3`N,#`P
M,#`R(B!X87!'.F)L86-K/2(P+C`P,#`P,"(O/@T*"0D)"0D)"0D)/')D9CIL
M:2!X87!'.G-W871C:$YA;64](D,]-C`@33TQ,"!9/34@2STP(B!X87!'.FUO
M9&4](D--64LB('AA<$<Z='EP93TB4%)/0T534R(@>&%P1SIC>6%N/2(V,"XP
M,#`P,#0B('AA<$<Z;6%G96YT83TB,3`N,#`P,#`R(B!X87!'.GEE;&QO=STB
M-2XP,#`P,#$B('AA<$<Z8FQA8VL](C`N,#`P,#`P(B\^#0H)"0D)"0D)"0D\
M<F1F.FQI('AA<$<Z<W=A=&-H3F%M93TB0STX,"!-/34@63TQ,"!+/3`B('AA
M<$<Z;6]D93TB0TU92R(@>&%P1SIT>7!E/2)04D]#15-3(B!X87!'.F-Y86X]
M(C@P+C`P,#`P,"(@>&%P1SIM86=E;G1A/2(U+C`P,#`P,2(@>&%P1SIY96QL
M;W<](C$P+C`P,#`P,B(@>&%P1SIB;&%C:STB,"XP,#`P,#`B+SX-"@D)"0D)
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M9CIL:2!X87!'.G-W871C:$YA;64](DL],3`P(B!X87!'.FUO9&4](D=205DB
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M/')D9CIL:2!X87!'.G-W871C:$YA;64](DL],C`B('AA<$<Z;6]D93TB1U)!
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M=&$^#0H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(#P_>'!A8VME="!E;F0])W<G/S[_X@Q824-#7U!2
M3T9)3$4``0$```Q(3&EN;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A
M8W-P35-&5`````!)14,@<U)'0@```````````````0``]M8``0````#3+4A0
M("``````````````````````````````````````````````````````````
M`````!%C<')T```!4````#-D97-C```!A````&QW='!T```!\````!1B:W!T
M```"!````!1R6%E:```"&````!1G6%E:```"+````!1B6%E:```"0````!1D
M;6YD```"5````'!D;61D```"Q````(AV=65D```#3````(9V:65W```#U```
M`"1L=6UI```#^````!1M96%S```$#````"1T96-H```$,`````QR5%)#```$
M/```"`QG5%)#```$/```"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H
M="`H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P``````
M```2<U)'0B!)14,V,3DV-BTR+C$``````````````!)S4D="($E%0S8Q.38V
M+3(N,0``````````````````````````````````````````````````````
M````````````6%E:(````````/-1``$````!%LQ865H@````````````````
M`````%A96B````````!OH@``./4```.06%E:(````````&*9``"WA0``&-I8
M65H@````````)*````^$``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W
M+FEE8RYC:```````````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````
M``````````````````````````````````````````````````````!D97-C
M`````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C
M92`M('-21T(``````````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="
M(&-O;&]U<B!S<&%C92`M('-21T(`````````````````````````````9&5S
M8P`````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q
M.38V+3(N,0``````````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO
M;B!I;B!)14,V,3DV-BTR+C$``````````````````````````````````'9I
M97<``````!.D_@`47RX`$,\4``/MS``$$PL``UR>`````5A96B```````$P)
M5@!0````5Q_G;65A<P`````````!`````````````````````````H\````"
M<VEG(`````!#4E0@8W5R=@````````0`````!0`*``\`%``9`!X`(P`H`"T`
M,@`W`#L`0`!%`$H`3P!4`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?
M`*0`J0"N`+(`MP"\`,$`Q@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!
M&0$?`24!*P$R`3@!/@%%`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q
M`;D!P0')`=$!V0'A`>D!\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$"
M>@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F
M`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$
MC`2:!*@$M@3$!-,$X03P!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075
M!>4%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'
M80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0
M"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+
M"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF
M#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/
ME@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F
M$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5
M$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;
M&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;
MBANR&]H<`APJ'%(<>QRC',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3
M'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC
M"B,X(V8CE"/"(_`D'R1-)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8
M)TDG>B>K)]PH#2@_*'$HHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDK
MG2O1+`4L.2QN+*(LURT,+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U
M,&PPI##;,1(Q2C&",;HQ\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U
M336'-<(U_38W-G(VKC;I-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT
M.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`
M(T!D0*9`YT$I06I!K$'N0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>
M1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),
M*DQR3+I-`DU*39--W$XE3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\
M4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9
M:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!7
M8*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-G
MZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X
M;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9W
MLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E
M@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(
MSHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&H
MDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;
M0INOG!R<B9SWG62=TIY`GJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'
MI3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O
M%J^+L`"P=;#JL6"QUK)+LL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*
MN<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$
M4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\W
MS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:
M^]N`W`7<BMT0W9;>'-ZBWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6
MYQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS
M&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M
M____VP!#``(!`0(!`0("`@("`@("`P4#`P,#`P8$!`,%!P8'!P<&!P<("0L)
M"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_VP!#`0("`@,#`P8#`P8,"`<(
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!>`0X#`2(``A$!`Q$!_\0`'P```04!`0$!`0$`````````
M``$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&
M$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ
M0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66
MEYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3E
MYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<(
M"0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(
M%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*
M4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.D
MI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T
M]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"BBB@`HHKQKX[?\%#_`(&_LT2W
M,'CCXK>!]"U"S_UNFMJD<^I+]+2(M.>G9#S6E.E.H^6FFWY*Y,ZD8*\G9>9[
M+17YT?%S_@YT_9W\"RR0^&;#X@^/I,'RIM/T=;&U8_[37DD,JCW$3'VKYH^*
M'_!USXNU%)(_!7P;\.Z.P)$=SKFNS:CN'8M##%!M^@E/UKU:/#^/J:JFUZV7
MYZ_@<%3-L+#>=_37\C]KJ*_G0^)/_!QS^U-XT+/9^*/"'@M3VT3PY`RK]/MI
MN3^M>86O[>O[7G[5E^T>A_$CXY>*[AGP8O"#WD9+>FS340?ABO1APCB;<U2<
M8KY_Y6_$XY9_0O:$6W\O\S^GZN8\8_&WP9\.BX\0>+O#&A&/[PU#5(+7;]=[
M"OYP+#_@F3^V5^TTOFW_`,.?BQKOF_,6\6:K]C8_4:E<1M^8S7H7@+_@V;_:
M6\41J;K2/AQX3W#[NJZ_N*_7[)#./R--\/X.G_%Q4?16_P#DOT$LVQ$OX=!_
MC_D?MMK7_!2W]G7P\9!>?'CX.Q21G#1CQCI[2#_@"REOTKCM;_X+1?LLZ`6\
M[XV>#9MO_/I)+=_EY2-FOS0\'?\`!JC\5KY4_M[XH_#S1_[PT^RO-0V_3>L&
M?TKT31/^#341NK:G\?'F7^)+3P4(2/HS7S_GBH^H9-'X\0WZ)_\`R+*^M9C+
MX:2^;_X)]BW_`/P7Y_9(TYRLGQ;C?'_/'PUK$P_-+0UGW'_!PW^R-"/D^)VH
M3?[G@_6Q_P"A68KY^T3_`(-2OAK$%_M/XL_$*Z/?[):6-MG_`+ZCDKHK?_@U
M9^`Z*OF?$#XU2-WVZEI2J?P_L\G]:GV&1K_EY-_=_P#(E>TS-_8C_7S/5#_P
M<5?LF@_\C]K1]_\`A$M6_P#D>G1_\'%'[)CMAOB!K2>Y\):M_2VKSFV_X-</
MV>H5^?Q1\7IO=]8L1_Z#9"K0_P"#7[]G3;_R&OBK]?[;MO\`Y%J?9Y'_`#5/
MP_R'S9GVA^/^9Z1!_P`'"W[(LP^;XIWD9]&\'ZY_,69%:FF?\%Z/V2]6;$?Q
M>LX_^OC0M4MQ^<ELM>-7'_!KC^SS,OR^)_B]#[IK-B?_`$*S-9T__!JU\!75
MO+\??&J-CTSJ>E,H_#^S\_K1[')']NI^'^0_:9G_`"Q_'_,^HM"_X+"_LO\`
MB(KY'QQ^'\.[I]LU$6?Y^<%Q^-=GX?\`^"@_P#\63K%I?QN^$6HS-C$=MXPT
M^5^?]E9B:^"M;_X-2_AG,K?V;\6/B+:GM]KMK&XQ]=L4=<3K_P#P:80W+-_9
MOQZDA7LMYX*6X/XE;U/Y4OJF3RVKR7K%O\D'UC,5O23]'_P3]=?"_CO0_&]O
MYVBZSI6L0XSOLKN.X7'U0FOP8_X./?VQ]2^/G[:<?PKT"]O[SPW\-8(K*33[
M21GBU+6IP))&V*<2/&CP0*""R2?:%&-Y%>@1?\$'8?\`@F#XEC_:"^('COPC
MXR\&?!]9/$W]EQZ3+I]WJVH0(3IMLI+R*N^^-J.6P?N]&)'SO_P1W^!'C']L
M']NO6OB-+I?_``FVM?#NWO?B'=PW$JV\>N^(&:273[=Y6(6)IK]O/W,0H6UD
MR:]7*<#A<-.>-IU.>,%H[<OO/IKUMZ;HX<?B:]:,<-.'+*3[WT773^M#]N/^
M"8G[`/AW_@G[^R_H/ANUTVP7QE?6<5UXKU9%5Y]2OV4-*OFXR88F)2)>BHH/
M+,S-]&5^#<UO_P`%3/V=?,NI6^*U]N9I',3:3XJ5R22=L0^TE1UPH48&``,"
MH7_X+Z?MF_LR(D?Q(\$:7Y:D"23QAX'OM%G8>S(]NBD^I0CVKSZV0XC$5'5A
M5A4;UTE_7YG73S2C1BH2IRBEW1^]5%?CG\*/^#L:&Z,,?C3X,R+&/];>^'O$
M:W#-_NV\T*`?C,:^GOA!_P`''7[+_P`3_+CU3Q!XH\!W4S!4A\0Z%-C)]9;3
M[1"H]VD`]Z\VMD./I?%3?RU_*YUT\TPL]IKYZ?F?=U%</\&OVG/AQ^T59-<>
M`?'G@_QG'&H>7^Q=8M[YH0<??6-B4/(R&`(/!KN*\N4)1?+)69W1DI*\0HHH
MJ2@HHHH`**\[_:C_`&J?`O[&OP>U#QS\0M<@T/0;%A"A8&2XOIV!*6]O$/FE
MF;:Q"*,X5F.%5F'X3_\`!0;_`(.!_BS^UO>WV@^`;B^^$_P_=FC2+3[C9KNI
MQYX-S=H<PY`!\JW*@;F5I)EP:];+<GQ&-=Z:M'JWM_P7_3L<.,S&EAE[^K[+
M<_8[]L+_`(*Q?`G]B![BQ\:>-K.X\36Z_P#(N:,O]HZL6P"%>*/B#<#D-<-$
MA[-7YI_M,_\`!TWXV\437%C\(_A]H_A6Q)9(]5\2RG4+]T/1A;0LD,+CT:2=
M:_*-45-V!C<2S'^\3R2?<^M?4W[`_P#P2!^,G_!04V^J>'=)C\,^!9'P_BO7
M%>&RF4-M;[+&!YEVPPPS&!%N0JTJ-Q7V-+A_+\'#VN)?-;K+1?)?IJ?.U,VQ
M>(ER45;R6_W_`/#'G_[0'_!0[XY?M2"XC\>?%3QCK=C=#;+IT=[_`&?IL@]&
MM+81P-@<99">O/)KG?V<_P!CCXG_`+5%XMK\,?AWXF\71^;Y#76G6)73X'_N
MRW;[;>(^TDB]#Z5^\O['_P#P;T?`']FBWM;[Q-I,GQ:\41@,][XFC633XWQ@
M^5IX_<!2>1YPF=3T>ON;3-,MM%TZWL[.W@M+2UC6*&"&,1QPHHPJJHX``&`!
MP*X\1Q50HKV>"IZ?<ON7_`.BCD=6H^?$S_5_?_PY^$'P"_X->?C1\08H;KQ]
MXN\&_#FUF7<;>!7US48C_=>.,Q0#ZK<./Z_9/P7_`.#8?]G_`,!K#-XOU3QW
M\0KK:!-%=ZF-,LF/^PEHL<RCV,S?6OT=K\4_^"MG_!PQK6M^*M5^'/[/>L+I
M.AZ?(]GJGC>VVR7&JR?<>/3F.5C@'(^TC+R-\T)15667SL/F&:YE4]G1ERKK
M;1+Y[_B==;"8'!PYZD;^NK?RV/T(3]E7]CO]@^ULKC5/"WP-^'TG6UU#Q(;&
M.\;M\MS>L96Y_P!L\UU5M_P5"_9GAC6&+X]?!R..$!%4>+;!54#@`?O,8X[5
M^)_[//\`P0%_:7_;`W>,O$UO9^"5UQ_M,VH^.;ZX;6]1W=96@"23[\CD7)B<
M]<$8)]N_XA2?B%_T6'P;_P""2Y_^.5I6R_+T[8G%.4OO_P`_S)IXS%M7HT++
M[O\`(_4B+_@I_P#LVR]/C_\`!A<?WO&>G+_.:O:/#_B"P\6:#9:II5]9ZEI>
MI0)=6EY:3+-;W4+J&22-U)5D92"&!((((K\2G_X-3/B0"=OQ<\$,.V=(NAG_
M`,?K]'/^"._[,?C3]C3]BNS^&?CK[.VL>%=<U.**2UG::SGMI;E[B*2!F"GR
MV$V[!4%6+*0""*\O,,'@:=+GPM;F=]5;IWZ?TSMPF(Q4Y\M>GRJVY]2T445X
MIZ04444`%([[$+'/RC/`R?RI:*`/#6_X*9?L]P^,I/#MQ\9OAS8:]#=MI\VG
MWNN06ES!<JQ1H)$D92D@<;2C`,&XQGBO<J_%G_@Z-_8GM]$\3>%?CIHVGQK#
MX@8>&?%9C08EN%C+65RX`Y+11RP,['I%;)Z5]T?\$.?VOS^U_P#\$]_"=UJ%
MVUUXI\#C_A%-=9V+22S6J((9V).6:6V:WD9NAD:0#[M>UBLMIQP4,;0;:>C3
MZ/\`K]#S:&,F\3+#54DUJGW7]?J?7U%%0ZGJ=OHNFW%Y>7$-I9VD;33SS.(X
MX44$L[,>%4`$DG@`5XIZ1^1/_!TS^UU_9WAWP+\#M+N=LNJ,/%GB%58J?L\;
M/#90MV97F$\I!Y#6D1[U]%_\&[_[(8_9M_8"TWQ/J%KY/B;XM3#Q+=,R`21V
M)79819[IY'[\`\JUW(.U?DE`NI?\%J/^"O?S"\_L;XC>)-S?>B?3_#MHG3N(
MY/L,`'8&>7U?G^EC3M.M]'T^WM+2WAM;6UC6&&&%`D<**,*JJ.`H```'``KZ
MS./]CP-+`+XG[TOZ]?R1X.7_`.T8J>+>RT7]>GYDU!YHHKY,]X\>^+?_``3Y
M^!GQV::3Q;\(_AYK5W<##WLVA6ZWOX7"J)5_!A7RS\8O^#:']FWXB*\GAV+Q
MM\/;C!*_V/KCW<);_:2^6X.W/\*,GH"*_0>BNRCF.*H_PZC7S=ONV.>I@Z%3
MXX)_(_#GXV_\&K_Q*\%WJZI\,_B7X5\4S6KF>"+5K2;0[Z`CE1'-$9U:3I\Q
M\H9]*\WO/VA/^"A'_!+4^9XI?XB2>&;#$DS^(X5\6:&8QPJO?JTK0)CHBW$1
MP,8&,#^@ZBO7AQ)6DN7%0C47FE?_`"_`\^634T^:A)P?D_Z_,_(?]EC_`(.I
MM%UK[+8_&/X>7.D,X56USPG-]LM2Q/+O:3$2Q(!S\DL['LM?I;^S5^V-\+_V
MPO"[:Q\-/&^@^+K6%5:XBM)MMW9;L[1/;.%F@)P<"5%)]*\<_:V_X(J?L\_M
M@BYO-6\$V_A/Q)<Y9M>\*;-*OF<G)>154P7#GINGBD..A%?E/^US_P`$'/CY
M^P+XC_X6!\)=:U;QUI>BDSP:MX7,NG^)M(7N6MHW+R+R%+6SN6`8M%&F:VCA
M\JQNE%NE/L]8O^O5>AFZN.PVM1>TCW6_]??ZG]`U%?BY_P`$V_\`@Y;U'2KW
M3_"7[1*QZEILA$%OXXTZU"3VQSP;^VC&UTY(,T"J5VKNB;+2#]E_#WB'3_%V
M@6.K:3?6>J:7JEO'=V=Y:3+-;W<,BATEC=25=&4A@RD@@@@XKQLPRW$8.?)6
M7H^C]/ZN>EA<92Q$>:F_EU1_,O\`\%<_V\]:_;T_;!U_4I+Z5O!/A*]N='\)
M6"R$P06L<FQ[H#@>;<M&)68C<%\J/)$:FOE^N^_:I^`.K?LK_M(^-OAWK4$T
M-]X2U>>R5I%V_:;?=NM[A?\`9F@:*5?:09P<BO/+YF2RF:/[X1BOUQQ7ZQA*
M=.%&,*/PV5O3_@[GP6(G.524JF]]3]2?^"$O_!%W2_VG]-M?C1\6M/2^\!PW
M+IX<\.3#]WXBEB<H]U=#^*T216183_KG1BX\H!9_W*T_3[?2-/@M+2"&UM;6
M-8H88D"1Q(HPJJHX"@```<`"N#_9)T30_#7[*WPUT_PR8V\.V?A;3(=,:,Y5
M[86D0B8'OE,'/?.:]"K\JS;,*N+KN<]D[)=E_GW/NL!A(8>DHQWZOO\`UT"B
MBBO,.T^`?^#BS]LN^_9C_8?7PKH-XUEXF^+-V^A)+&^V:WTY8]]](A_VD,=N
M2,%1=[@05!KYG_X-L_\`@F9HOBO16_:&\;:7'J#6M_)9>!K2X0-;P/;L8Y]2
MV\AI%F5H8LX\MH97P6,;)SW_``==:M=3_'7X,V,C-]AM=!U2>`'[HDDN+99,
M>^V*+/T%?IK_`,$G]`T_PW_P3.^`\&FK&L$W@?2KV0)T,\]LD\Y^IFDD)]\U
M]9.H\+DT/9:.HW=^6NGX+\>YX,8JOF4N?:"T7GI_G^1]!45\D_\`!9K_`(*(
MZU_P3;_92L?%GAC1])U;Q-XBUV'0=/.J;VLK$M!/<//*B,C2`1V[*$#I\TBD
MDA2I_*'_`(B@OVCO3X0_^".X_P#DRO-P.0XK%TO;4K6VU9VXK-*%"?LYWN?T
M*45_/=#_`,'/7[25RVV./X2R-C.%T&Y)_P#2ROTI_P""?G_!8#_A?/\`P32\
M<?'/XG:3I^B7/PPOKW3M972`RV^J20VUO<Q?9HY79D>47<,(1I&S+GY@&`#Q
MG#^,PT%.:3NTM'U>PL/FV'K2Y8M[7U\CZZ^-?Q\\$_LX>!Y?$GC[Q5H/A#0H
M7$?VS5;Q+:.20@D1IN(+R,%.$7+-C@&OE6?_`(.'?V28-6-M_P`+*U)HU.TW
M*>$M8:$'_P`!=Q^H4CWQS7Y%_#[X=_'3_@X&_;6U*_O=1CMX[%?/O;VYWR:-
MX%TZ1R([>",8W.VPA$&U[AHG=V4*\B?H-IW_``:I?!^/PE'#>?$SXJS:]Y6'
MNX7TZ*S:7'WA;FU9PG^R9B?]JN^>4Y=A$H8ZJ^=[J/3\'_70Y8X[%U_>PL%R
M]WU_%'Z$?L^?M2_#G]J[PD^N?#GQGX?\8:;"56X?3;M9)+-V!*I/%_K(7(!.
MV15;'.,5WU?S=_M6_L=_&K_@A!^T[X9\7>&_%2W%K?L_]@^*-/A>&WU-4*M-
MI]_:ECC(VL86=TD7#H^^-A%^TGA'_@J3X/UO_@E\/VF;RU>VTFUT1[N\TE9O
MWB:FDOV5M/5R.KWN(4=E`8.CD`&N+,,G]DH5<++GA-V3ZW[/^EYI'1A,PYW*
MG77+*.K[6[GM7QX_:0\`_LP>"SXA^(7B[0?!^C[C''<:G=K!]HDP3Y<2D[I9
M,`D(@9CC@5\OI_P<-_LDOJ_V7_A96H",G`NCX2U@0Y_\!=WXE<=\XYK\C/@G
M\"_CC_P7]_;(UK7=:UR&WCL0DFK:S<1/)I7A&RD=O)LK*WW`D_*^R(.ID*/)
M+)O+2-^@,_\`P:H_"(^#6AB^)WQ27Q%Y.!>N=.:Q$O\`>-M]F#[/]GS\_P"W
M7;/*LNPMJ>-JOGZJ.R_!_P!=#GCCL97]_#07+W?7\5_74^QOC;H/PW_X*O?L
M->-?"_A+Q=X=\4:#XNT][.UU33KI;J'3=0CVS6SR!#N62&=89#&V&^7!`S7Y
M!_\`!N]^TQJ7[)O_``4%UCX4>+(Y='M_B'YOAZ_LKDA6T[7;!Y3"CD_=;(N[
M<@<M))"/X17F/Q)^&?QS_P"#?S]M73=0T_4HYEO%,^GZC;B2/1O'&G1N!+;7
M$1)VLN]0\9+/`TJ.CD-'(VQ_P6$T6UL_V@/AO^U%\*YKC2?#OQPL+;Q?I=Q'
MM$VA^(+)HA<QL%RJRI(L$A.3NF%QC(4FO6P>70A3EA(SYJ597B^TE^NE_P#M
MW9'GXC&2E.-=QY9TW:2\G_5OF?T:5\&?\'$?[70_9O\`V`M2\+Z?=>3XD^+4
MQ\-6RJP\R.Q*[[^7'=#!^X)'(:[C-?4W[&?[2VF_MA_LL^!OB7I:QQP>+=+C
MNIX(VW+972YCN;?/<Q7"2Q$]S&:_"?\`X+H?M#:M^W1_P4[?P'X35M4M_!=W
M#X!\/V:.=EWJLDZI=-S]UVNV6W8],6:'UKY[(LO=3'<M565/5_+I]_X7/7S3
M%*&%O#>6B^?_``#ZM_X-;_V2U\.^"?'7QVUF%8&U@MX7T&24;-EG"RRWLX8_
M*4>=88\]5:RD[&OK+XQ_\%[?V6_@SXAFTF;XD+XDOK9MLH\.:;<ZK;K]+F)#
M;MCN$D)'<5^6O_!5#]I?5/"T'A/]B?X.SZA<^"?AO;V7AC6(]+C(N?'6O/M\
MV)E0DNOVB4YA&`]S)+N5A'$1])_LF_\`!K/H=Y\/;/4OC5XY\20>)+R)99-%
M\*26T-MI1/\`RRDN)HIC<.!C+1K&H;(&\`.WJXW"X6I-X[,9M*?PQ6_+TOH^
MFO3UOH<&&KUH1^K82*?+\3>U^I]L?`/_`(+-?L\_M-WC:9X-\<)?^)V3-MX>
MO;232M2U*3M!:K=B*.XF/9(I&-2_LH?\%A?@9^V5\6KCP'X1U[5[?QE'#--%
MI&LZ/<:9<7?DY\Z./S5"F6,`EHB0X"NVTJCE?S,_X*6?\&X=[^S5\*=6\??"
M'Q)K7C30?#MNU[JV@ZU'$VK0VZ#=)<6\T*1QS[!EC$8T<*C%6D;"'Y\_X(3Z
ME<:U_P`%B/@[>W=Q/>7=Y>:W<3W$\AEEN)'T+4V9W=B2S,226)))))J5DN7U
M<+4Q.&FVHIM=TTKV>G7^FRGF6+IUX4:T4KM+U3=M#]D_V@O^"X/P7_93^)=U
MX/\`B)8_$;PGXCM8Q,;2[\,3,L\1)59H98RT4T196421.R;D89RI`^E?@-\>
M?"7[3?PDT7QUX&UFWU_PMX@A,UE>Q(\>\*S(ZLC@.CHZLC(ZAE964@$$5XO_
M`,%3/^"<NA?\%(/V<+CPW.;+3?&>AE[[PKK<R'.G79`W1.R@M]FG"JDJ@'@(
MX4O%&1^/?_!(O_@H;XB_X)0_M5:Y\,?BI;ZCHO@75=5;3_$^G7/S/X5U-<1C
M4%`)5HR`BRE"1)#Y<J%_+19/.P^64,9A'4PM_:QWBW>Z\M/ZV[,[*V-J8?$*
M%:W)+9]GY_UY]S]^OBM\5?#OP.^&^M>+_%NK6NA>&_#MH][J%]<D^7;Q(,DX
M`+,3P`J@LS$*H)(!^4?@S_P7@^!7[17Q-T_P;X#B^(?BOQ-JSE;2QL?"UQND
M48S(S/M6*-<@M)*41`1N*U^=?_!?O_@IU-^UW\7+7X&?#*[N-9\%>'=1BBU%
M],4SGQ9K6_9%;PA,F:*!V"HHXDN"2%;RH7/Z-?\`!&;_`()@V?\`P3O_`&?%
MN=>M;6;XK>,8TN?$MXK++]A7K%IT+KD>7#GYF4D22EVR5\M4)Y90PN"5?%WY
MY?#%.VG=Z?UHO0CC:E?$NE0MRQW?^1]BV\K36\;M&\+,H8H^-R$]C@D9'L2/
M>GT45\\>L?G'_P`%EO\`@B#H'[5_A36OB9\+=+M=$^+MC&][>65L@BM?&B@%
MGCD7A4O3R8Y^/,;Y)<@I+#\A?\&_G_!5J#]F,^(_A;\2]:FMOA]'9OK&@2W.
MYFT6[\]%GM$4\B.;S3+LX"/%*<$RMC]V:_`>'_@F''_P41_X*[_M*>'_``G=
MII/@[PIK5Y>WFJA2UO!J4UQ'YEI\H/SM/]O.`,`6[`XXS];E.+AB<)4PN-?N
M12:?5:VM_E\UL>#C\/*CB(5\,O>D[-=_ZZ_>?I=_P5K_`."07AO_`(*3>#K?
M5]/NK7PO\5/#UJT&D:V\9:WOH06<65Z%&YH"[,5=07A9V90X:2*3^?/]I/\`
M9=\?_L@_$N;PC\2/#&H>%]:7<\`N%W6^HQ`@>=;3+F.>/D?,A.TG:P5@5']:
MU<?\<O@!X)_:7^'UUX5\?>%]&\6>'[H[VL]1MQ,L;@$"6,_>CE4,=LB%77.0
M0:Y,HXBJX1>RJ+FA^*]/\OR-LPRF&(?M(:2_!^O^9^77_!OI_P`%>-'G\%:#
M^SS\2M2CTW6-,(L?!.KW4NV#4H"?W6F2,W"3QYV0<A9(]D0`D1?-_76OR%_;
M&_X-9=)UY[O4_@;XT_L;SLL/#7BMGNK(9/W(KU%::-`.`)8YV8]9!7.?`_\`
M;Z_;"_X)(6L'AS]H+X7^+?B)\,-,'EIKL;"^NM*@!P&74HB\4J8W%8KQDEY`
M\R-5"CHQV!PV.DZ^7S7,]7!Z._E?\MNSZ&>%Q-;#15+%Q=EM):KYG[.T5\]_
ML<?\%2O@=^W996Z^`?'&FS:[-'O?P]J+"QUB+`RP%NYS*J]Y(3)'_MFOH2OF
MJU&I2ER58M/L]#V:=2%2/-!W7D?EK_P=*_LV7GCS]FSP+\4-/@DF_P"%<ZK-
MI^I[%'[JRU'R4$S'J0MS!;1@=OM!/K75?\&V7[:NF_&C]D'_`(5/J%["GC#X
M5O(D-O))^]OM)FE:2"=`?O+$\C6[!<[`D!;!E7/Z#?$CX=:)\7OA_K7A7Q+I
MMOJ_A_Q%92Z=J-E/GR[JWE0I(AP01E21D$$=00>:_G;_`&W_`-@KXO\`_!%'
M]I>P\>>"=6UM?"5K?&3PMXUM45S;ASC[#J"[?+64J=C+(ODW*\J,[XHOI\LE
M3QV"_LZH^6<7>#?Y?B_D[]#Q,;&>%Q/UR*O%JTO\_P`OZ9_0=\4_@)X1^-VI
M^&KCQ=H.G>(E\(Z@=7TN"_A6>"VO/)DA6XV,"K.D<LH4D$*7W#Y@I&C_`,*I
M\+_]"WH'_@OB_P#B:_+K]EC_`(.F?".L^'[:Q^,W@76M`UQ`$EU7PO&M]IEP
M<<R&"219X/0(IG]=_:O>E_X..OV5&4'_`(2[Q,N>Q\*ZAQ_Y"KRZN3YC3?(Z
M<G;MJOP.ZGF&$FN936O?3\SD?^#DCX?Z#H?_``37GNK+0]'L[J'Q1IGES0V4
M<<D>6D4X8+D9!(..Q([U^=_P?U#4+7_@W%^,<-GYGV.[^,UE'J`'3R1:Z,ZY
M]O.2#\<5]%?\%J?^"OWP+_;:_8CN/`_P]\0ZQJ7B*37;"^6"YT*[LT,43,7/
MF2QJO`(XSD]JV?\`@A3^S%IG[9G_``1K^/'PQU:;[);^+/&UY;PW6SS/L-TF
MEZ1+;7&W(W>5/'%)MR,[,9&:^BP?/A,NC+$Q:Y:B;NM;71X^(Y:^,<:+3O!K
M3O9GJ_\`P:U:-I%M^P?XQO[-8VU>\\<W46I2;1Y@\NRLO)CSUV!'W`=`97]3
M6Y_P6W_X++>+/^";_C3P;X1\`^'O#&I:_P"(+&36+Z^\113S6=M;"0PQQQQ0
MRPLTCNLA+&0!`BC:Y?*?F?\`L-?ML?$S_@AQ^UIXK\)^,_"]S=:;<31V?BSP
MTTOER2>7N\C4+&5AM)VNQ1N(YXV"L5(1XOT,?_@KE^PC\:/C':_%3QIJ%Y)X
MKCT"'0;.Q\1^";Z_;185FFFDV>3!/`))#,%9T=OEB`!`9MV.,R^<<>\5.FZM
M.6JY=;W6E[=%]UON-</C(O"JA&:IS6COIU/S4_;D_P""VOQ1_P""A'P8A\"^
M/M#^%5MI-KJ<.KV]QHVF7EO>6]Q$LB*R/->S(`4ED0_)DJY`(KLH'\3Z5_P;
MCR,\-]#H>M?&T&WD=2L5UIRV`^=#T:,:A"RY''F(PZBOTC/_``6!_P""?Y_Y
M??#'_ALM1_\`D"O3OB!JOP;_`."V'[`7CWP/\+_%VEZCI\EO'96LJ64]C)H&
MH0%)[)I;:6-)HX1)$G1`)(Q(JD\XVEF7LHTX_5I4Z:DFVT[+\-S*.#]HY2]L
MIR<6DE:_YGE__!LGH^BV'_!-N:ZTWRFU/4/%NI2:R5.6%PHA2-6]/]&6W('H
MV>]?H=7\X_\`P3R_X*#?$/\`X(I?M)>+/`OCWPGJLV@S7J0^*_"[2+'>6%R@
M`2^LV8^4[-$5(.X1W,7DD2`!''ZBS_\`!R/^RU%X(_M1?$/BZ;4O*W_V(OAB
M[%\6Q]SS&46N[MGS]OOWKR\ZR?%2Q4JM*+G&;NFM=_3_`(:QW9;F%!4%3FU%
MQT:>FQPO_!TKH^DW/[!W@^^O%B75K/QS:Q:=)M'F'S+*]\V,'KM*)N(Z$Q)Z
M"O`/V6OV2=3_`&V_^#;[5=#AM9;SQ!X%\1:MXC\'(%+/));2O++!&!U:<37T
M*CIYDP)Z5\T_MW?MO_$K_@N!^UAX3\)^"_"UY;Z9;S26?A'PRD@DF#2;?/O[
MV51M#;$4NW,=O&A`+$R22?O=^Q)^R[IW[%W[*7@?X8Z9<?;(?"FG"&XNPA07
MMW([374X4D[1)<22N%R=H?&3BNS%3GEV`HT9O]YS<UNR5_\`AOO.>C&.,Q52
MI'X.7EOWV_K[C\7?^".?_!6RW_8P_8H^.WA?5+V*34-$TT^*?`D,WSI<WUP8
M[-[8`G[@N)+.8HH)V/=R=$)IW_!M9^R5<?'G]L_5OBIKR3:AI?POMFGCN+DF
M0WNLWJR(CL6!$C)#]IE8_>61X&ZX-?/'_!8K]D./]B']O;QMX=M+9;7PKK3_
M`/"4>'@JA8X[&Z9V:)0.%6"=;B!1UV1(3]ZOW;_X([?L<2?L1_L$>#_#.HV;
M6?BK7$/B/Q(CKMD34+I49HG'3=!"L%N2.#]GSWKNS;$4*&$G7H?%7M]UM?UO
MYLY<OHU:N(C2J[4K_??3_@>2/QZ_X)10P^*_^"]VFS>+OWNJR>+?%-ZR7"[O
M,U(0ZA(2P.?F5_,<'J'12.0*_HEK\"?^"X_[%OC+]@G]N5/C]X#-Y8>&O%FN
MQ^(K/5[6+>OA[7_,$LL4V<J5GF!F7>-DGFRQ%2%^?[&_9._X.;O@]\0/`UG%
M\7;/6/ASXKMX56^EL]-N-4TB\D`P7MS`LDZ!B-WERQ_)N"^9)C>?/SK!U<="
MEC,*N:/*DTM6FO+YV^1UY;B(8:4\/7?*[WN]G\S],#S7\Y/_``1_TS1M%_X+
MP>";+PX8CX=L_$_BF#23$<QFS32]76#:?[OE!,>U?5W_``4J_P"#DOP_XJ^%
M>K>"_@!#KQU/6X'M+GQA?VS:?'IT#C#-91,1,9RI8"218Q$<,H<_=^*O^""*
M)%_P5R^":QA5C6;6`H7H!_8.I8Q6^4Y;7PV!Q%2LN7FB[+KHGJ_O,L?C*5;%
M484W>TEKZM']+M?B;_P=,^%?A5I7Q3\!:GIK-;_&;5+9CK$%JB^3=Z.H=()[
MOG(F693'"P&7C696)$407]3/V]_VV/#/[`'[-.M?$3Q,/M;6N+32=+2813:W
MJ$@;R;6,D'&[:S,P#;(XY'P0A%?AK_P3H_9`\9?\%JOV\M?\<?$FZN+[PO:W
MZ:UXVU%2\*79.!;Z3;$'<@9$$8"MF&WB/SAS%N\_AW#NG*6857RP@G\WV_KK
M;Y=F;U>=+"05Y2_#S_KI<T/^#=!_A+!^W_:GXAL5\5?8BO@#[3M_LW^TCN$N
M[_IZ\GBWW?)DS?\`+7R*_H@K\(?^"]__``2>_P"&2_'$?QN^%.FS:1X"U2\B
M?5[/2P8%\(:F9%\FY@,>##;S2;-N,"&?`4@2QHGV5_P2S_X+N_#WX[_L^V]A
M\;/'GA'P'\1_#*"UU"ZUN^ATJS\01J!LO8GD*Q"1QQ)$I!616*HJ,@K?/,.\
M=".8X:\D]&MW%^GY_?LS'+:JPTGA*UD]T^_]?\#H?HI17D_@7]KWP_\`&V&.
M3X;Z?KGCJSGY36+:QDL]#VG.V5;^X5(KB+=P39_:'7D[#W]$N-"'BCPZ+37+
M>VF%PO\`I5M%(S6[@]8FSCS4P=I#*%<9RH!VCY65.4'::M^?W'O1FI*\=3Q?
MXU_&#QK\;8M1\#_`][>UU&9GL=5^(5[!YVC>%!DI+]D3(&I:@A#JL*'R(9$;
M[1*K(MO-V'[(_P"R1X+_`&)_@M8^!O`]G<PZ?;RO=WM[>S?:-0UN]DQYU[=S
M8!FN)"HW-@`!550J(B+Z1964.FV<-O;PQV]O;H(XHHT"I&H&`J@<``#``Z5)
M6DJ[Y/90TCOZOS].G1>K;<QIKFYY:O\`+T"BBBN<T"BBB@#Y[_:&_P""4G[.
M_P"U'=2WGC#X3^%9]6FD\]]5TV!M)U)Y!R':YM6BE<@C(WL1[5S/A']@+XF?
ML^^6GPI_:0\>1Z7$VY="^(UC#XTTU%'"Q)*6MK^.,`8"B[('IP`/JJBNJ..K
MJ/(Y779ZK[G=(P>&I<W,E9]UH_P/%_#OQ#^.'@U/+\7_``Y\)^+((QM%[X)\
M1>7=W+?WC8ZBD$4*^POI3U]@>MF^(>@^/M$NM%\3>&]9L[>_@:WU'3]<T-Y;
M+RW!#1S3*LEFZ$$@XE9"#C-=W16<JD7KRV]+_P#!+C!KK?U/@GXV_P#!NI^S
M'\>=0DU70]/\1?#^2Z<R2'PAJR1VDA)_A@N(YX8E[;8410.@%>8G_@U2^#N>
M/B9\6,=LR:;_`/(E?J)17=3SO'07+&J_GK^9RRRW"R=W!?D?EW_Q"I?!W_HI
MGQ8_[^:;_P#(E?4G_!.C_@F%I7_!-6SU_3/"/Q`\9>(/#?B2=;VZTG7$M)(8
M;H((_M$+0PQ,CLB1JVXLK+&G`(S7U!14XC-L76@Z=6=T^FG^15++\/2ESTXV
M9XW^U]^P#\)?VZ_#=OI_Q+\'V.N36*LMAJ<3O:ZGIV<Y$5S$5D52<,8R3&Q5
M=RM@5\3ZK_P:L?!.XO7>S^(GQ=M86)(B>ZTV;9[!OL8.![Y/N:_3RBHP^:8N
MA'DI5&EVZ%5L%0JOFJ139^7?_$*E\'?^BF?%C_OYIO\`\B5]`?\`!/C_`((Y
M>&?^";7Q&U?7_`WQ&^(&I0^([6*TUC2M8^PRV5^(B[0N1%;QR+)&9)=C!\`2
MN"&SQ]B45=;.,95@Z=2;:>ZT_P`B:>7X>G)3A&S1X?\`ME?\$Y?@_P#MZ:1;
MP_$CPC;:EJ5A$8;'6;61K/5+!<D[4N(R&,>YBWE/NC+<E":^.4_X-6_@6NK^
M:?B!\8FLL[OLYO\`3-Q]B_V'.WMTSCOGFOTVHJ,/FF+H1Y*51I=BJV!H59<T
MXIL\8_8^_P""?7PC_81\/7%C\-?!]EHMU?*%O]4F=KO4]0`QQ+<R%I"F1N$8
M(C4DE47)KV>BBN2I5G4DYU&VWU>IT0IQA'E@K(^??VR?^";/P\_;C^)_PO\`
M%?C)=274/A;JO]I6D=J8A#JL9DBE:TNU=&\R`R01$J"#C>`0';/T%111.M.4
M8PD]([+M?44:<8R<DM7N9OC'P9H_Q$\+7^A^(-)TW7=%U2%K>]T_4+5+JUO(
MFX9)(G!5U/<,"#7Y_P#QD_X-D_V=_B1XDFU+0+[X@?#]9CN.GZ-JL5Q8ACU(
M6[AGD7V59`HS@*``!^B5%;87'8C#N]";CZ?Y&=;"TJW\2*9\+_LR_P#!O#^S
ME^SEXJM]<O-+\0?$C5+*036Q\77D5U:V[CN+6&*&"3GD><DF#@C!`-/\0_\`
M!!OX=V_[94WQR\%^//B-\/?%\NM2^(%ATJ>RGLH;R;>;ED2XMY&\N;S)=\;,
M5Q,ZJ%7"K]RT5L\VQCDY.HVVK.^JMVML9_4<.DHJ"T=_F?"O[87_``0VTO\`
M;O\`']MXA^)7QO\`BYJ\VFQO#IMA`-,M]/TE'(+B"!;3"ERJ[G8M(X1`SL$4
M+]-?L=_L@>"OV&?@-I7P]\!V=Q!H^FL\\UU=LLE]JES(<R7-S(JJ))6P!D*%
M551%54157U"BLJN.KU*2HSE[JV6B7X%T\+2A-U(KWGUZF3X[\#:/\3O!6K>&
M_$&G6NKZ%KUG+I^H6-RF^&[MY4*21N.ZLI(/UKYU_9L_X(U?LW_LK:LNI^&_
MAGI.H:U%)YL.I:_))K5S:L&RIA-TSK"RC@-&%8@<DDDGZ@HK*GB:M.+A"32>
MZ3:OZFDJ-.4E*44VMM`HHHK$T.1^/UUXDL?@5XSF\'+,WBR'0[U]%$,<<DIO
M!`Y@V++^[9_,VX63Y"<!N,U^>-EXJ^-UO>^*C\%]6U37O$W]KR#3K1-1M]2^
MRZ']NU-<ZD+D)Y.H>6FD@)J'F7NP2E9F)O(;?]/**[<+C%1BXN*E?O\`K_7<
MYZV']HT^9KT"BBBN(Z`HHHH`****`"BBB@`HHHH`*\__`&K_`(Q_\,\_LO\`
MQ$\>?)YG@[PWJ&L1*V,2206TDB)SP2S*J@=R0*]`KXO_`."_NKZK!_P3!\;Z
M/HSPPWWBBZT_2Q-+(42./[5'/*"0I.'CA>/&/^6E=6!HJKB(4GLVE^)CB:GL
MZ4IKHF?,OP'_`."Y>B>%/^"2NK7'C+XVV/B']I:;0M8DM('L(UN;>_>2=-/7
MRXK=;<^6GV=V!!!PV<UT7PH_;%^.'BGX[_L)_#&Z^(FIR:W\0/"MQX_^(<[:
M98A]6L9XWO+2"4"W`A54MIK?,0C)+C)W`-5C_@LE^Q=H?PS_`.":OPV^%_@S
M0?!^EZQK&N:#X/N-=;3HXKHPPVTC&7S5C,C.TEM$6R06!;)YP>X_9E^$DFO_
M`/!>7XL>(I%L8_#_`,*_A]IG@WPY9AF:6UBDCM)MV,84*3=*,,<K-G@YQ](_
MJCHSKTX;\\M4G;:*MHK*\KI=+7['C?OU4C2G+;E6E_5WUWM&U_,\O_9Q_P""
MM/C_`.$__!(SXM>/OB/XBF\8_%;POX\U#X?>'6GL+>.;4-4,%L;:(001QI)Y
M1EDF90NYD@<`DXKU?QEXR^.'@GP!^RO\"M>^(FL7WQL^*VNC6O'.N6T5M!-I
MNBV"_;=2MHVMXUBCQN@LXY0F)#O/5L5\]?L$_L0:E\2_^"O/Q-C\2:I87'PW
M^$OQ'\0?$/2=!B9SYVLWMVL5K+(I0#]Q';QN#N)62!`H*R25]!>"OB_]K_;$
M_:]_:*U"Q_M3_A1FD1_#3POI;2^0P2UA&HWQD8!E`N+N:$"0`NL<7*G`6C%4
MZ,*K]E%7MS[+>5HPBO)-\SZ/;H.A4J."YV_Y=^BUDWYM*R.?_P""SW_!0?XH
M^#?%NH_##]GO7ET3Q3\//"]W\0O'^N1VUM=?V/IL,0$%D!-'*GG3-(LA78'"
M^0P.QY"NE_P4<_;Z^(EE_P`$]?V==8^%'B-O#?Q(_:!U;P[8V-Y%9V]Q+$M]
M9^;(5BFC>/\`USP1D;<CS.,5Y#\`/^"0FN_'K]B_QM\8O&/QP^*6E_$CXUZ3
MJ.O>(['POK,=CX=U<.ER;:VNX6MFDG@$<A5HBP1$E>*,!0&;A_V//!VN_'WX
MJ?\`!/'POXCDT]M,^&NEZ_K4HCF=O/DM[R\2SV`H`?+_`+*MN6Q@,^,]]*>%
MPL8Q4;2]DWS:;M1DW>^ZO&R\B)5J[DV[KVB5M=ES)?)V>OF>]:EX_P#VBOVY
M/^"G/QT^'?PK^/\`<_"?P#\';;2K0S1^$M/UP7-Y/;@R*PF".&,R70)\P@>0
M`%&>.6\`_P#!4;]H;P=^Q3^UII&O0Z3XT^,_[-FI6VFPZ_8Z8HAU"VN;N2W>
M]DMHE6/-M%!<W.0B)Y8C$B#9(S?.G[&'[<WQ>_9]^*GQ<F\$>%_AKJ/BKXY>
M,+G7FU77[^]\NQ:665H86BAC!:.-II#PX^^1T`KZFU+]AWXX?\$UOV(-<^(G
MA#XFZ#??&:^\:+\0?B;>75H#IOBJV_>&73$8P&18_,D+AU6%F,T^#$&C6/2M
M@XTFJ52$;>XH:*[:MS7:5[/5:WW6A%/$.:<X2E]IRUV3O:R;M=:/3L9'[!WQ
ME^+GQ>^*'PO\2?#7]KSPS\?+?5IH9_B1X(\16EIH]YIEB^Q;BYL[=$$ZF`NV
MT*$C9UCRS(Q6OO7]JC]M#PS^R'KWPSL?$NF>(KW_`(6IXML_!FESZ;!#)#9W
MMTVV)K@R2H5BZDL@=@%/RGO^:'_!/K7%_P""KW_!2CP3\;O#/PV\!_!'2_@Z
MMY/X@71KQ[C5O%ES=0201^8Z6T$91=S`EAOV/(I+AU\OZI_X+_>%]5OOV-?"
MOBC09K&'7?AO\0=&\5Z<;S<83/`9HT#!021F;)'&0#R*X,=A8RQU.A45KK56
M2:;;LFXJSZ:I;:,ZL+7DL-.K!WL]'J[VM??5==.YZ%\0/^"N7PM^&_C7XR:3
M>6?C"ZL_@9;V9\1ZQ8:?'=6,M[=LBV^FVVR4S37;.S*5\L1QF*3S)$"DU#\'
MO^"M'@KX@?%O6/!/B_P3\3O@SKVC^$Y?'$B>/-,MK".32(CB6YWPW$P01X8L
M)-A&QQR48#X\_:E^"WCC_@GG_P`$E_A[K6B>,-4-]K?C.T\:?&'4=(UJYT?6
M?&<M^3-<PP7\2>;%N8QP^8HC9DB5SR71_//V8_V+KC]LWXG?M13>&X+?P+-X
MH^%6G:-X6MK[Q1J?B)X(M12"_!O;Z[#3L9&MXE?:'$2RNB"0)NDNGE6%E2E4
M=^5:<WFG&-[>;;>STLM&M9ECJZJ*"M?>WJF]_)6737NMOM[X7_\`!<CX8?$S
MXA>!],D\$_&#PSX7^)NL_P#"/^$?&FN^&UM/#_B&]9S'#%#()FFS,_RQ[X5R
M<[M@5B*GQ$_X+T?"'P!JGB2^C\*_%KQ%\-_!NLIH.N_$?1_#J7/A/3+LR)&R
MM<F99)%1Y$4M%$X8R1^7Y@EC+>+?\$I/VU_BS^UWJ/@3X2>&]/\`"/P]\#_!
M'PW%H7C&\6[EU'4O$)@M4M+8V"F"-;1=\>]M[.P#X!)4%O,/^"='QU^-?[/^
MI^'_`-ASP39?#C0?%W@7Q#>MK?CN>XN+^VN=.^TS7-SY%D8$+7.URL;22!,1
M*I`W;UJ63TU*:=/6-FUS?9;E[S=M[):*^][=`682<8M2T=];==-+7VU>KMMO
MU/J[XM_\%(]!^&'[:GQ7U2Z\<>.+KP!\"_A_9:CK_AG3/#^FR:5?W=\\4MI<
M0Z@\XN)+B6&ZC18=L<)"AM^0=W2_!7_@M%\/_C5\>?AWX#3P#\9/"[?%:Q:^
M\*ZYXB\-I8:3K*K:_:7$,AF,CA5^7S$C:,DH5<QR1R/^?OQ_^$?B+XR?!3]I
MV_.H6,-]^T-^T/IG@.69I'S9Z7IKR7-H6^0_O%!C&T9'R=<5]A_&/X(3?''_
M`(+<^"='M[R/1/#OPK^#VI3Z4MN2)K.[OGDTYWB4#;M6WN(L?,#F+IT-16P.
M%C"TUJHO7:W+&/9:WDW\D%/%5W*\=KK\9/[O=7WG4^(_^"[GPET#5-4U"+PG
M\6M6^&&A:PNAZE\3M/\`#@F\'V<YD6(L;GS1*\2R,$,D<+*2R;-X="W2?'C_
M`(*^>"_@Q\6/'?A'2?A]\7/B9<_"VTMKSQC?>#M%M[RS\.)<1F6,2M-<PL[>
M6"Y\I7`57R<QN%_*[]F+]EFR\8_%72/V0]1^&G@S4_''AG6;BT\6^*M3^(/B
MF30=2TZ">6:8VND6D]HBW`3;L)=49X0S`&0M'V__``4*TC4O$?[?/B+X;V?@
MKPGX-_:,UC7K2W\!_$WP9XIU;08[72'\A;2/5(`)3-=K;*D<DT?7Y0H"Q#S.
MMY)A565-1ELWJUM=)2WZZWV:T]W1IXK,JWLW-M;I==[.ZV]/+?7J?MI\//'F
MF?%/P!H?B?19I;C1_$>GV^J6$LD#P/);SQK+&S1N`Z$JP)5@&'0@'BMBL_PI
M87VE>%]-M=4OAJFIV]K%%=WHA$(O)E0!Y=B\)N8%MHX&<5H5\;*U]-CZ&-[:
'A1114C/_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
